###begin article-title 0
ATP and MO25alpha Regulate the Conformational State of the STRADalpha Pseudokinase and Activation of the LKB1 Tumour Suppressor
###end article-title 0
###begin p 1
The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: EZ BMF DRA DMFvA. Performed the experiments: EZ BMF SG IN JB MD DMFvA. Analyzed the data: EZ BMF IN DRA DMFvA. Wrote the paper: EZ DRA DMFvA.
###end p 1
###begin p 2
The conformation of the pseudokinase STRADalpha, which is regulated by binding to ATP and to the scaffolding protein MO25alpha, is key to the activiation of the LKB1 tumor suppressor complex.
###end p 2
###begin p 3
###xml 1260 1265 <span type="species:ncbi:9606">human</span>
Pseudokinases lack essential residues for kinase activity, yet are emerging as important regulators of signal transduction networks. The pseudokinase STRAD activates the LKB1 tumour suppressor by forming a heterotrimeric complex with LKB1 and the scaffolding protein MO25. Here, we describe the structure of STRADalpha in complex with MO25alpha. The structure reveals an intricate web of interactions between STRADalpha and MO25alpha involving the alphaC-helix of STRADalpha, reminiscent of the mechanism by which CDK2 interacts with cyclin A. Surprisingly, STRADalpha binds ATP and displays a closed conformation and an ordered activation loop, typical of active protein kinases. Inactivity is accounted for by nonconservative substitution of almost all essential catalytic residues. We demonstrate that binding of ATP enhances the affinity of STRADalpha for MO25alpha, and conversely, binding of MO25alpha promotes interaction of STRADalpha with ATP. Mutagenesis studies reveal that association of STRADalpha with either ATP or MO25alpha is essential for LKB1 activation. We conclude that ATP and MO25alpha cooperate to maintain STRADalpha in an "active" closed conformation required for LKB1 activation. It has recently been demonstrated that a mutation in human STRADalpha that truncates a C-terminal region of the pseudokinase domain leads to the polyhydramnios, megalencephaly, symptomatic epilepsy (PMSE) syndrome. We demonstrate this mutation destabilizes STRADalpha and prevents association with LKB1. In summary, our findings describe one of the first structures of a genuinely inactive pseudokinase. The ability of STRADalpha to activate LKB1 is dependent on a closed "active" conformation, aided by ATP and MO25alpha binding. Thus, the function of STRADalpha is mediated through an active kinase conformation rather than kinase activity. It is possible that other pseudokinases exert their function through nucleotide binding and active conformations.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
###xml 14 19 <span type="species:ncbi:9606">human</span>
There are 518 human protein kinases that are responsible for orchestrating the phosphorylation-dependant signal transduction events that regulate almost all cellular processes. Curiously, approximately 10% of protein kinases lack one or more catalytic residues, and these kinases have been termed pseudokinases. It has been proposed that some pseudokinases act as scaffolds, bringing together proteins involved in signalling networks. Here, we report the structure of the pseudokinase STRADalpha in complex with the adaptor protein MO25alpha; together these two proteins regulate the LKB1 tumour suppressor kinase. Despite lacking several key catalytic residues, STRADalpha binds ATP and adopts an active conformation typical of catalytically competent kinases. The affinity of STRADalpha for ATP is enhanced by MO25alpha and vice versa. We go on to demonstrate through mutagenesis studies that binding to both ATP and MO25alpha is essential for the activation of LKB1. Our data suggest that STRADalpha exerts its functions through an active conformation, not through actual catalytic activity, thus raising the possibility that pseudokinases regulate signalling networks by adopting different structural conformations.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 108 111 108 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Manning1">[1]</xref>
###xml 112 115 112 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau1">[2]</xref>
###xml 236 239 236 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau1">[2]</xref>
###xml 558 561 558 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Min1">[3]</xref>
###xml 601 603 601 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 767 769 767 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 775 778 775 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Mukherjee1">[4]</xref>
###xml 908 911 908 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Najm1">[5]</xref>
###xml 990 992 990 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1072 1075 1072 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Kawagoe1">[6]</xref>
###xml 901 907 <span type="species:ncbi:9606">humans</span>
###xml 1138 1143 <span type="species:ncbi:9606">human</span>
Pseudokinases are classified as protein kinases that lack key catalytic residues within their kinase domain [1],[2]. These proteins are emerging as important regulators and scaffolding components of various signal transduction networks [2]. Despite being predicted to lack intrinsic kinase activity, several "pseudokinases" such as WNK, CASK, and IRAK2 still possess the ability to phosphorylate substrates. In the case of WNK isoforms, the missing conserved catalytic Lys residue in subdomain-II is substituted by another Lys residue located in subdomain-I [3]. CASK, despite lacking the conserved Mg2+ binding Asp residue in the DFG motif of subdomain-VII, folds into an active conformation capable of binding ATP and phosphorylating substrates in the absence of Mg2+ ions [4]. Interestingly, recent studies have shown that mutations in CASK affect brain development and cause mental retardation in humans [5]. Recent data also indicate that the IRAK2 pseudokinase, despite lacking the Mg2+ binding DFG motif as well as the catalytic HRD motif, still possesses activity [6]. These results suggest that some of the other proteins in the human genome that are classified as pseudokinases may still possess catalytic activity and thus function as normal kinases.
###end p 7
###begin p 8
###xml 157 160 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Baas1">[7]</xref>
###xml 161 164 161 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau2">[8]</xref>
###xml 444 447 430 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Hemminki1">[9]</xref>
###xml 564 568 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-SanchezCespedes1">[10]</xref>
###xml 728 732 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Alessi1">[11]</xref>
###xml 939 943 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Inoki1">[12]</xref>
###xml 944 948 930 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Gwinn1">[13]</xref>
###xml 169 175 <span type="species:ncbi:9606">humans</span>
###xml 383 389 <span type="species:ncbi:9606">humans</span>
The STe-20 Related Adaptor (STRAD) pseudokinase forms a 1:1:1 heterotrimeric complex with the LKB1 tumour suppressor kinase and the scaffolding protein MO25 [7],[8]. In humans, there are two closely related isoforms of STRAD (STRADalpha and STRADbeta) and MO25 (MO25alpha and MO25beta) that similarly interact with and activate LKB1. Loss-of-function mutations in the LKB1 kinase in humans result in the inherited Peutz-Jeghers cancer syndrome [9]. Inactivating mutations in LKB1 are also increasingly being reported in sporadic cancers, in particular lung cancer [10]. LKB1 exerts its tumour-suppressing effects by phosphorylating and activating AMP-activated protein kinase (AMPK) as well as a number of other related kinases [11]. LKB1-mediated activation of AMPK occurs when cellular energy levels are low, and activation of AMPK inhibits cell growth and proliferation through multiple pathways, including suppressing activity of mTOR [12],[13].
###end p 8
###begin p 9
###xml 219 223 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYK5</italic>
###xml 276 280 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Puffenberger1">[14]</xref>
###xml 410 414 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Puffenberger1">[14]</xref>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 571 579 <span type="species:ncbi:9606">patients</span>
Recently, it was reported that a severe human developmental and epileptic syndrome termed polyhydramnios, megalencephaly, symptomatic epilepsy (PMSE), was caused by a homozygous partial deletion in the STRADalpha gene (LYK5), truncating 180 C-terminal residues of the protein [14]. Individuals affected by this condition suffer from severe mental retardation, gross movement disorders, and childhood mortality [14]. How this mutation affects STRADalpha function and its ability to interact with LKB1 is unknown, although histological staining of neuronal tissues of PMSE patients has suggested elevated mTOR pathway activity, which could potentially result from loss of LKB1 kinase activity.
###end p 9
###begin p 10
###xml 152 155 145 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Baas1">[7]</xref>
###xml 156 159 149 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau2">[8]</xref>
###xml 229 232 222 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Baas1">[7]</xref>
###xml 389 393 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau3">[15]</xref>
###xml 725 728 703 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau2">[8]</xref>
###xml 933 937 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 1160 1164 1119 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Graham1">[17]</xref>
###xml 1165 1169 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Wang1">[19]</xref>
###xml 1350 1354 1305 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 1652 1656 1587 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau3">[15]</xref>
###xml 375 380 <span type="species:ncbi:9606">human</span>
Unlike the majority of kinases that require phosphorylation of their T-loop, LKB1 is activated through direct interaction with STRADalpha/beta isoforms [7],[8]. The kinase domain of LKB1 binds to the pseudokinase domain of STRAD [7]. At least 12 point mutations located in the LKB1 kinase domain that prevent LKB1 from interacting with STRAD isoforms have been identified in human cancers [15]. Activation of LKB1 and interaction with STRAD isoforms is markedly enhanced in the presence of MO25alpha/beta isoforms, indicating that MO25 stabilizes the interaction between STRAD and LKB1. The C-terminal Trp-Glu-Phe residues (WEF motif) of STRADalpha bind to MO25alpha, and mutations of these residues abolish this interaction [8]. Structural analysis of MO25alpha revealed a helical repeat, horseshoe-shaped protein that interacts with the WEF motif of STRADalpha through a hydrophobic pocket located on its convex C-terminal surface [16]. In contrast, proteins that are distantly structurally similar to MO25alpha, such as the Armadillo repeat proteins PUM1, beta-catenin, and importin-alpha, interact with their binding partners through their concave surface [17]-[19]. Many of the surface-exposed residues on the MO25alpha concave surface are conserved between species, suggesting that these may mediate interactions with (an) unknown regulator(s) [16]. Although STRADalpha mutants lacking the C-terminal WEF motif are unable to interact with MO25alpha alone, they can still form a heterotrimeric complex with LKB1 and MO25alpha, demonstrating that STRADalpha possesses additional interactions with LKB1 and/or MO25alpha, separate from the WEF motif [15].
###end p 10
###begin p 11
###xml 232 234 228 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 240 243 236 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Baas1">[7]</xref>
###xml 244 248 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau3">[15]</xref>
###xml 426 430 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau3">[15]</xref>
All studies undertaken to date suggest that STRADalpha expressed in bacteria is incapable of autophosphorylating or phosphorylating other substrates tested (MBP, histone 2A, or LKB1) when assays were undertaken in the presence of Mg2+ ions [7],[15] (J. Boudeau, unpublished data). Despite lacking detectable kinase activity, STRADalpha is still capable of interacting with ATP as well as ADP in a magnesium-independent manner [15]. Mutations that abolish ATP binding do not affect the ability of STRADalpha to activate LKB1 in the presence of MO25alpha. Thus, the role of ATP-binding to STRAD is unclear.
###end p 11
###begin p 12
###xml 1118 1123 <span type="species:ncbi:9606">human</span>
Here, we report the structure of STRADalpha as part of the STRADalpha/MO25alpha heterodimer. The data show that despite being inactive, STRADalpha folds into an ATP-bound, closed conformation with an ordered activation loop similar to that of fully active protein kinases. Our data establish that STRADalpha is indeed deficient in intrinsic catalytic activity because it lacks most essential catalytic residues. Moreover, we observe that STRADalpha does not only interact with MO25alpha through its WEF motif as previously envisaged, but forms an extensive network of interactions with the highly conserved concave surface of MO25alpha. Binding studies and mutagenesis data show that the closed/"active" conformation that STRADalpha assumes is maintained through cooperative binding of ATP and MO25alpha. STRADalpha mutants incapable of interacting with ATP and MO25alpha are unable to activate LKB1, despite interacting with it. We conclude that the ability of STRADalpha to activate LKB1 is dependent on an active conformation rather than catalytic phosphoryltransferase activity. Our results also indicate that the human mutation that causes PMSE syndrome destabilizes STRADalpha and prevents it from binding to, and activating LKB1.
###end p 12
###begin title 13
Results and Discussion
###end title 13
###begin title 14
STRADalpha Adopts the Canonical Kinase Fold
###end title 14
###begin p 15
###xml 120 124 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Dorfman1">[20]</xref>
###xml 216 219 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau2">[8]</xref>
###xml 220 224 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 396 412 380 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 590 599 566 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s001">Figure S1</xref>
###xml 672 673 640 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 674 675 642 643 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 676 677 644 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 715 722 683 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-1000126-t001">Table 1</xref>
###xml 770 774 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Walter1">[21]</xref>
###xml 884 891 852 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-1000126-t001">Table 1</xref>
###xml 1153 1154 1121 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1154 1158 1122 1126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">free</sub>
###xml 1159 1160 1127 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1160 1164 1128 1132 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">work</sub>
###xml 1181 1188 1149 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-1000126-t001">Table 1</xref>
###xml 1425 1434 1382 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1A</xref>
###xml 1550 1566 1507 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1A and 1B</xref>
###xml 1791 1795 1748 1752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Knighton1">[22]</xref>
###xml 396 412 <span type="species:ncbi:562">Escherichia coli</span>
STRADalpha comprises a pseudokinase domain (residues 58-401), two nuclear export sequences (residues 21-29 and 417-426) [20], and a C-terminal WEF motif (residues 429-431) previously shown to interact with MO25alpha [8],[16]. We focused on the interaction between the STRADalpha pseudokinase domain (residues 59-431) and full-length MO25alpha (residues 1-341). These proteins were coexpressed in Escherichia coli and the STRADalpha/MO25alpha complex eluted as a heterodimer of the expected size from a gel filtration column, yielding approximately 60 mg of the complex from 4 l of culture (Figure S1). Initial crystals of the STRADalpha/MO25alpha complex in space group P212121 diffracted only to 4.8 A resolution (Table 1). With the help of chemical lysine methylation [21], diffraction of these crystals (retaining the same space group and unit cell dimensions) improved to 2.35 A (Table 1). The structures of both methylated and unmethylated crystals were solved by molecular replacement and revealed the same packing/intermolecular interactions. The high-resolution, methylated form of the complex was refined to a final model with good statistics (Rfree/Rwork of 0.254/0.206; Table 1). The structure of STRADalpha exhibits the classical bilobal protein kinase fold, with the N-terminal lobe (residues 59-152) organized around a central beta-sheet, and a C-terminal lobe (residues 153-401) that is largely alpha-helical (Figure 1A). A well-resolved molecule of ATP was observed in the cleft between the small and large lobes of the pseudokinase (Figure 1A and 1B). The ATP molecule displays the canonical binding mode and retains a similar conformation to that of ATP molecules bound to active kinases (root mean square deviation [RMSD] = 0.9 A on all atoms compared to ATP bound to PKA [22]).
###end p 15
###begin title 16
STRADalpha structure, active site, sequence motifs, and interactions with MO25alpha.
###end title 16
###begin p 17
###xml 290 294 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Knighton1">[22]</xref>
###xml 498 499 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 499 500 488 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 501 502 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 502 503 491 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 748 752 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Zhou1">[23]</xref>
###xml 1056 1058 1033 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1946 1960 1895 1909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s003">Figure S3B&#8211;S3F</xref>
(A) Overall structure of STRADalpha shown in cartoon representation (N-terminal lobe coloured brown, C-terminal lobe coloured green) with transparent molecular surface. For clarity, the WEF motif has been omitted. Secondary structure elements are labelled according to the structure of PKA [22]. The activation loop is coloured yellow, with the section that appears to be unique to STRADalpha/beta (residues 221-229) coloured red. The ATP molecule is shown in stick representation, and an unbiased Fo-Fc electron density map is shown in magenta, contoured at 2.5sigma. Dotted lines represent regions that were not well defined by electron density and are not included in the refined model. (B) Superposition of the STRADalpha and TAO2 (PDB ID 1U5R [23]) active sites, highlighting key residues required for activity. STRADalpha residues (labelled) are shown as stick models with yellow carbon atoms; the corresponding TAO2 residues are shown with blue, transparent carbon atoms. Water molecules are represented by red spheres, and gray spheres represent Mg2+ ions from the TAO2 structure. The glycine-rich loop and part of the activation loop have been omitted for clarity. (C) Multiple sequence alignment of STRADalpha and other pseudokinases, highlighting (in yellow) key motifs that are normally essential in active eukaryotic protein kinases. (D) Crystallographic contacts between MO25alpha (blue) and symmetry-related STRADalpha molecules shown in cartoon representations. The STRADalpha WEF motif bound to MO25alpha is shown as sticks with green carbons. Dashed lines represent the distance from the last residue of the C-terminal lobe of each STRADalpha molecule able to donate the WEF motif, corresponding to 52, 83, 65, and 55 A (straight-line distances) for molecules A, B, C, and D, respectively). An additional tight crystallographic contact, through the MO25alpha N-terminus ("PFPF motif") is also indicated and further discussed in Figure S3B-S3F. (E) Structure of the STRADalpha (green) MO25alpha (blue) complex. Residues that make direct contact are shown as sticks, with hydrogen bonds shown as dotted black lines.
###end p 17
###begin title 18
Summary of data collection, structure refinement, and analysis.
###end title 18
###begin p 19
Values for the highest resolution shell are given in parentheses.
###end p 19
###begin p 20
asu, asymmetric unit.
###end p 20
###begin title 21
###xml 31 33 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
STRADalpha Binds ATP Using a Mg2+-Independent Mechanism
###end title 21
###begin p 22
###xml 393 409 389 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1B and 1C</xref>
###xml 618 622 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Zhou1">[23]</xref>
Sequence comparison reveals that STRADalpha lacks numerous essential catalytic residues found in active protein kinases, namely a conserved Gly residue in the glycine-rich loop (subdomain-I), the Lys residue of the VAIK motif (subdomain-II), the catalytic Asp residue of the HRD motif (subdomain-VIb), a conserved Asn residue (subdomain-VIb), as well as the entire DFG motif in subdomain-VII (Figure 1B and 1C). Despite missing these key residues, STRADalpha adopts a similar overall conformation to that of TAO2 (sharing 25% sequence identity and 37% sequence similarity), an active protein kinase of known structure [23] (RMSD = 1.4 A on 197 Calpha atoms). Comparison of the STRADalpha and TAO2 structures reveals that a number of substitutions of key catalytic residues are found in STRADalpha. Met83 replaces one of the conserved Gly residues in the glycine-rich loop, Arg100 substitutes the catalytic Lys residue in the VAIK motif, Ser195 replaces the Asp residue in the HRD motif, His200 substitutes for the conserved Asn in subdomain-VIb, and the entire DFG motif is replaced by GLR (residues 213-215).
###end p 22
###begin p 23
###xml 84 86 84 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 335 337 320 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 405 406 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 493 495 474 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 623 632 593 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1B</xref>
###xml 824 826 791 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 833 842 800 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1B</xref>
###xml 858 860 825 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1065 1067 1024 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1465 1467 1416 1418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1510 1514 1461 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau3">[15]</xref>
In active protein kinases, the DFG motif plays a pivotal role in coordinating two Mg2+ ions: one that orients the gamma-phosphate into the position required for phosphoryl transfer and the other that controls ATP conformation by interacting with the beta/gamma phosphates. Consistent with the lack of the DFG motif in STRADalpha, no Mg2+ ions were observed in the STRADalpha-ATP complex, despite 1 mM MgCl2 being present in the crystallization mother liquor. However, despite the absence of Mg2+ ions, the positioning of the beta/gamma phosphates in STRADalpha was similar to that of active TAO2 kinase complexed to MgATP (Figure 1B). The beta-phosphate is tethered through interactions with Arg215 from the GLR (DFG) motif, and His200 (subdomain-VIb), basic residues that may substitute for one of the positively charged Mg2+ ions (Figure 1B). The second Mg2+ ion and its coordinating residues are also missing; instead, the gamma-phosphate only interacts with a conserved lysine (Lys197) in the catalytic loop. Thus, STRADalpha appears to have evolved a novel, Mg2+-independent mechanism to bind the phosphate groups of ATP. The presence of the two hydrogen bonds between N1 and N6 atoms of the ATP adenine ring and the protein backbone, observed in all active protein kinase structures, further illustrates the conservation of the ATP binding pocket. Thus, the STRADalpha structure explains previous observations that STRADalpha can bind ATP in the absence of Mg2+, and its similar affinity for ADP and ATP [15].
###end p 23
###begin title 24
STRADalpha Adopts an Active Conformation
###end title 24
###begin p 25
###xml 231 240 227 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1A</xref>
###xml 410 419 406 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1B</xref>
###xml 608 624 600 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1B and 1C</xref>
###xml 862 866 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Nolen1">[24]</xref>
###xml 975 979 946 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Johnson1">[25]</xref>
###xml 980 984 951 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Huse1">[26]</xref>
###xml 1112 1121 1079 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1B</xref>
Although the activation loop of STRADalpha (residues 212-245) is not phosphorylated, it is well ordered, a feature normally observed only in structures of activated protein kinases that are phosphorylated on their activation loop (Figure 1A). Remarkably, Asp232 in the activation loop occupies a position similar to the activating phosphorylated residue found in active kinases, e.g., (phospho)Ser181 in TAO2 (Figure 1B). Asp232 appears to play the same structural role as the activating phosphate group, coordinating the conserved arginine from the catalytic HRD motif (Arg194 in the STRADalpha HRS motif) (Figure 1B and 1C). Further evidence that STRADalpha adopts the canonical active conformation stems from the presence of a short antiparallel beta-sheet between the beta6 and beta9 strands, which is a characteristic feature of the active state of kinases [24]. Furthermore, the STRADalpha alphaC-helix is rotated into the "closed" conformation found in active kinases [25],[26], with the conserved ion pair between the Glu118 on the alphaC-helix and Arg100 in subdomain-II formed via two water molecules (Figure 1B).
###end p 25
###begin p 26
###xml 154 161 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 227 236 219 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s002">Figure S2</xref>
###xml 334 335 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 523 532 507 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s002">Figure S2</xref>
###xml 664 666 648 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 690 699 670 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s002">Figure S2</xref>
###xml 154 161 <span type="species:ncbi:562">E. coli</span>
Despite STRADalpha binding ATP in the correct orientation for activity and folding into an active conformation, STRADalpha (residues 59-431) expressed in E. coli did not autophosphorylate or phosphorylate myelin basic protein (Figure S2). We have attempted to detect activity in the presence and absence of MO25alpha and/or 10 mM MgCl2. We have also generated mutations converting all the missing catalytic residues on the STRADalpha pseudokinase discussed above to the equivalent residues found in the active kinase TAO2 (Figure S2). However, none of these mutants showed autophosphorylation or phosphorylated myelin basic protein in the presence or absence of Mg2+ ions and/or MO25alpha (Figure S2). We also tested whether STRADalpha possessed ATPase activity, employing a highly sensitive ATPase assay kit (Innova Biosciences), but no activity was observed (E. Zeqiraj, unpublished data). Nevertheless, it is impossible to categorically rule out that STRADalpha will not, highly specifically, phosphorylate an as-yet unidentified substrate.
###end p 26
###begin title 27
Identification of the Biological STRADalpha/MO25alpha Complex
###end title 27
###begin p 28
###xml 197 201 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 386 390 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 418 428 390 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s003">Figure S3A</xref>
###xml 542 543 506 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 850 860 806 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s003">Figure S3A</xref>
###xml 1269 1278 1205 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1D</xref>
###xml 1476 1480 1404 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Nooren1">[27]</xref>
###xml 1526 1527 1454 1455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1660 1661 1588 1589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1668 1669 1596 1597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1675 1676 1603 1604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1687 1688 1615 1616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1733 1742 1661 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1D</xref>
###xml 2081 2090 2001 2010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1D</xref>
###xml 2384 2393 2296 2305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1D</xref>
###xml 2452 2456 2364 2368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Krissinel1">[28]</xref>
The asymmetric unit of the STRADalpha/MO25alpha complex crystals contains one molecule of MO25alpha, with a conformation similar to the previously published MO25alpha/WEF peptide complex structure [16] (RMSD = 0.6 A on 292 Calpha atoms), and one molecule of STRADalpha. The position and conformation of the WEF motif is similar to that in the previously described MO25alpha/WEF complex [16] (RMSD = 0.3 A on 35 atoms, Figure S3A). Due to tight crystal contacts (total buried surface on MO25alpha by STRADalpha and its symmetry mates = 2,833 A2), it was not immediately apparent which contacts represented biologically relevant interactions and which were crystallographic packing artefacts. Whereas clear electron density is present for the last six amino acids of STRADalpha (residues 426-431, including the WEF motif that interacts with MO25alpha, Figure S3A), residues 402-425 of STRADalpha were not visible in the electron density maps, and it was thus not possible to directly identify the appropriate symmetry mates of STRADalpha and MO25alpha that make up the biologically relevant binary complex. Analysis of the crystal contacts between symmetry-related molecules suggested that there were four possible ways in which STRADalpha could interact with MO25alpha (Figure 1D). We studied all four possible STRADalpha/MO25alpha complexes and ranked these in terms of total buried surface area, a possible method for distinguishing crystallographic from biological contacts [27]. Discounting the WEF motif interaction (800 A2 buried surface area), identical in all four possible complexes, the buried surface area in each of the possible complexes is 1,550 A2, 225 A2, 58 A2, and 200 A2 for complexes A, B, C, and D, respectively (Figure 1D). In addition, the distances between the last well-defined residue of the STRADalpha C-terminal lobe and the first well-defined residue of the WEF motif at the extreme C-terminus of STRADalpha were measured for the four possible complexes. This yielded direct distances of 52, 83, 65, and 55 A for complexes A, B, C, and D, respectively (Figure 1D). Taken together, it appears that complex A is the most likely biological interaction, since STRADalpha binds to the (highly conserved) concave surface of MO25alpha and has the largest buried surface area, while also possessing the shortest distance from the C-terminal lobe to the WEF motif (Figure 1D). Similarly, analysis of the possible complexes with PISA [28] yields the highest (1.0) complexation significance score (CSS) for complex A, while predicting that complexes B, C, and D will not be stable in solution.
###end p 28
###begin p 29
###xml 80 81 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 310 319 286 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s004">Figure S4</xref>
###xml 530 540 494 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s003">Figure S3B</xref>
###xml 765 783 709 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s003">Figure S3C and S3D</xref>
###xml 939 949 879 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s003">Figure S3E</xref>
###xml 1063 1070 991 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1135 1145 1055 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s003">Figure S3F</xref>
###xml 1458 1462 1370 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Xiao1">[29]</xref>
###xml 1063 1070 <span type="species:ncbi:562">E. coli</span>
The 6-His purification tag that extends from the N-terminus of STRADalpha (450 A2 buried surface area in complex A) forms additional contacts between MO25alpha and STRADalpha. SPR studies demonstrate that His-tagged STRADalpha binds MO25alpha in vitro with the same affinity as STRADalpha lacking the His tag (Figure S4). Furthermore, MO25alpha residues 2-5 (Pro-Phe-Pro-Phe, termed the PFPF motif here) make hydrophobic contacts in a pocket adjacent to the STRADalpha ATP binding pocket on a symmetry-related copy of STRADalpha (Figure S3B). This is unlikely to constitute a physiological STRADalpha/MO25alpha interaction, as deleting this motif did not impair the in vivo interaction of MO25alpha with either STRADalpha alone or a complex of STRADalpha and LKB1 (Figure S3C and S3D). Moreover, we were unable to affinity purify overexpressed STRADalpha or LKB1 from a cell extract employing a PFPF motif containing biotinylated peptide (Figure S3E). A complex of LKB1/STRADalpha/MO25alpha(DeltaPFPF) still activated the heterotrimeric AMPK complex expressed in E. coli with similar efficiency as wild-type LKB1/STRADalpha/MO25alpha (Figure S3F). Nevertheless, it is possible that the PFPF docking site on STRADalpha does play a role in enabling STRADalpha to interact with other regulators or substrates of the LKB1 complex. Intriguingly, a similar crystallographic interaction can be observed in the structure of the mammalian AMPK heterotrimeric complex [29]. In this case, a similar hydrophobic N-terminal motif "MYAF" from the beta2 domain interacts with the kinase domain from the neighbouring molecule in the crystal lattice, albeit not near the phospho-nucleotide binding site.
###end p 29
###begin title 30
STRADalpha Interacts with the MO25alpha Concave Surface
###end title 30
###begin p 31
###xml 162 166 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 292 296 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 416 425 396 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1E</xref>
###xml 594 598 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Graham1">[17]</xref>
###xml 599 603 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Wang1">[19]</xref>
###xml 862 872 819 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figures 1E</xref>
###xml 877 878 834 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g002">2</xref>
###xml 1069 1079 1006 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figures 1E</xref>
###xml 1084 1086 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g002">2A</xref>
###xml 1192 1201 1125 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1E</xref>
###xml 1228 1229 1161 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
MO25alpha is composed of seven structurally similar alpha-helical repeats (named R0-R6) that form a horseshoe-shaped molecule with a concave and a convex surface [16]. MO25alpha helical repeats R1-R6 consist of three alpha-helices (H1-H3) each, whereas repeat R0 consists of only two helices [16]. Helices H3 from repeat R1-R5 are arranged in an almost parallel fashion and make up the concave surface of MO25alpha (Figure 1E). Other helical repeat adaptor proteins, such as PUM1, beta-catenin, and importin-alpha, make use of a similar concave surface to interact with macromolecular partners [17]-[19]. Strikingly, the crystal structure of the STRADalpha/MO25alpha complex reveals that, in addition to the interaction through the WEF motif, a major additional binding interface involves the STRADalpha N-terminal kinase lobe and the MO25alpha concave surface (Figures 1E and 2). Part of the interaction surface on STRADalpha is N-terminal to the alphaC-helix and comprises the loop between the alphaB/alphaC helices (residues 104-109), termed the "alphaB site" here (Figures 1E and 2A). This region forms an extensive hydrogen-bonding network centred on Arg227 from the R5-H3 of MO25alpha (Figure 1E), burying a total of 245 A2 surface area. Residues Tyr223, Arg227, Lys231, and Asn269 of MO25alpha engage the side chains of residues Glu105 and Asn109 of STRADalpha, whereas Leu104, Ala106, Cys107, and Ser108 contribute to the interaction via their backbone atoms.
###end p 31
###begin title 32
Sites of the STRADalpha/MO25alpha interaction and sequence conservation.
###end title 32
###begin p 33
###xml 120 124 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Collaborative1">[42]</xref>
###xml 658 680 614 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 684 696 640 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 730 739 686 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s005">Figure S5</xref>
###xml 285 289 <span type="species:ncbi:159033">lime</span>
###xml 658 680 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 684 696 <span type="species:ncbi:9606">Homo sapiens</span>
(A) STRADalpha/MO25alpha complex and the interaction surface, as defined with the program CONTACT from the CCP4 package [42]. Surfaces of atom pairs closer than 3.9 A are coloured red. The MO25alpha surface is coloured grey, and the N- and C-lobes of STRADalpha are coloured brown and lime green, respectively. Arg240 is shown as sticks. To aid visualization, on the right side of the figure, the complex is "opened up" by rotating the STRADalpha molecule about the vertical axes -90degrees and MO25alpha +90degrees with respect to the binary complex. (B) Sequence conservation (dark blue = conserved, white = not conserved) of STRADalpha and MO25alpha from Caenorhabditis elegans to Homo sapiens (sequence alignments provided in Figure S5). The putative LKB1 binding pocket and the Arg240 site are indicated with an arrow. STRADalpha and MO25alpha are shown in the same orientation as in (A) to aid visualization of conserved areas that are buried in the STRADalpha/MO25alpha complex.
###end p 33
###begin p 34
###xml 138 148 122 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figures 1E</xref>
###xml 153 155 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g002">2A</xref>
###xml 248 257 228 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1E</xref>
###xml 343 344 319 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The alphaC-helix of STRADalpha runs along the concave surface of MO25alpha facing the H3 helixes of the MO25alpha repeats R4, R3, and R2 (Figures 1E and 2A; termed the "alphaC site" here). Tethered by hydrophobic and hydrogen-bonding interactions (Figure 1E), the alphaC-helix forms the major interaction surface, contributing a total of 405 A2 buried surface area on the MO25alpha concave surface.
###end p 34
###begin p 35
###xml 108 109 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 225 235 209 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figures 1E</xref>
###xml 240 242 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g002">2A</xref>
###xml 362 371 338 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1E</xref>
C-terminal to the alphaC helix, a second hydrogen-bonding network with comparable buried surface area (270 A2) to the alphaB site is present, and involves residues Leu124, Asn126, and Tyr185 from the STRADalpha helix alphaE (Figures 1E and 2A; termed the "alphaE site" here). This region interacts with Glu93, Lys96, and Phe92 from the R1-H3 helix of MO25alpha (Figure 1E). Together, the alphaB site and the alphaE site appear to act as anchor regions, positioning the alphaC-helix to run along the H3 helices of R1-R5 of MO25alpha.
###end p 35
###begin p 36
###xml 214 224 194 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figures 1E</xref>
###xml 229 231 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g002">2A</xref>
###xml 387 396 360 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1A</xref>
###xml 560 569 529 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g002">Figure 2A</xref>
###xml 765 774 722 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g002">Figures 2</xref>
###xml 779 781 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s005">S5</xref>
Additional interactions are found between Phe178 of MO25alpha, forming hydrophobic stacking interactions with residues from the N-terminal beta4 and beta5 strands of STRADalpha (termed the "beta4/beta5 site" here; Figures 1E and 2A). STRADalpha and STRADbeta also possess an insertion of ten residues (221-229) in the activation loop that is not observed in TAO2 or other STE20 kinases (Figure 1A). Within this insertion, His223, Gly224, and Arg226 show weak interactions with the R0 and R1 helical repeat of MO25alpha (termed the "activation loop site" here; Figure 2A). This interaction perhaps explains why the STRADalpha activation loop is ordered. All of the key interacting interface residues are highly conserved between species of STRADalpha and MO25alpha (Figures 2 and S5).
###end p 36
###begin title 37
The MO25alpha Concave Surface Is Required for STRADalpha Binding
###end title 37
###begin p 38
###xml 656 665 588 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figure 3A</xref>
###xml 808 812 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 1014 1023 922 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figure 3A</xref>
###xml 1308 1317 1194 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figure 3A</xref>
###xml 1494 1503 1372 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figure 3B</xref>
The structure of the STRADalpha/MO25alpha complex shows that, in addition to the WEF binding pocket on the convex surface of MO25alpha, a major network of interactions between STRADalpha and the concave surface of MO25alpha is observed over the alphaB, alphaC, alphaE, beta4/beta5, and activation loop sites. To test the importance of these additional interactions, we investigated how mutations of residues located on the MO25alpha concave surface affected interaction with STRADalpha. We mutated residues in MO25alpha in the novel alphaB, alphaC, alphaE, beta4/beta5, and activation loop binding sites as well as the previously characterised WEF pocket (Figure 3A). As reported previously, mutation of Met260 in the WEF pocket of MO25alpha abolishes its ability to interact with STRADalpha in HEK293 cells [16]. However, we also observed that mutations in the two anchor regions (Phe92, Glu93, and Lys96 from the alphaE site and Tyr223 and Arg227 from the alphaB site) abolished MO25alpha binding to STRADalpha (Figure 3A). Similarly, mutating Phe178 in the beta4/beta5 site, Ile145 and Ser182 in the alphaC site, or Arg107 in the activation loop site markedly disrupted the MO25alpha-STRADalpha interaction. Mutations of Leu141, Lys231, and Asn269 in the alphaC site did not significantly affect binding (Figure 3A). Mutation of the reciprocal interacting residues on STRADalpha, including Glu105, Asn109, Asn126, Ile138, and Tyr185, also abolished or markedly reduced binding to MO25alpha (Figure 3B). These results confirm the importance of the network of interactions between the concave surface of MO25alpha and STRADalpha in enabling the stable association between these two proteins, at least in the absence of LKB1.
###end p 38
###begin title 39
Mutation of MO25alpha concave surface residues abolishes STRADalpha and LKB1 binding.
###end title 39
###begin p 40
(A and B) The indicated constructs of GST-STRADalpha and Myc-MO25alpha were expressed in 293 cells. Cells 36 h post-transfection were lysed, and GST-STRADalpha was purified with glutathione-Sepharose. The purified GST-STRADalpha preparation (upper panels), as well as the cell extracts (lower panels), was immunoblotted (IB) with the indicated antibodies. Similar results were obtained in three separate experiments. Dotted line indicates the junction of two gels. AL, activation loop. (C and D) Two hundred ninety-three cells were cotransfected with the indicated constructs of GST-LKB1, Flag-STRADalpha, and Myc-MO25alpha. Cells 36 h post-transfection were lysed, and GST-LKB1 was purified and assayed for its ability to phosphorylate the LKBtide peptide. Kinase activities are representative of three independent assays carried out in triplicate (error bars represent the standard deviation for one experiment). Affinity-purified GST-LKB1 preparation (upper panel), as well as cell extracts (lower panel), was immunoblotted with the indicated antibodies.
###end p 40
###begin p 41
###xml 230 233 218 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau2">[8]</xref>
###xml 234 238 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau3">[15]</xref>
###xml 425 434 401 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figure 3C</xref>
###xml 618 627 572 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figure 3C</xref>
###xml 777 786 723 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figure 3C</xref>
Previous work has shown that MO25alpha mutants in which the WEF pocket was disrupted, and that were no longer able to form a complex with STRADalpha, were still capable of forming a heterotrimeric complex with LKB1 and STRADalpha [8],[15]. Similarly, MO25alpha mutants in which key STRADalpha binding residues located within the concave surface were mutated are still capable of interacting with the LKB1/STRADalpha complex (Figure 3C). Even double MO25alpha mutants in which both the WEF pocket and the alphaB, alphaE, or beta4/beta5 sites were disrupted were capable of associating with the LKB1/STRADalpha complex (Figure 3C). Moreover, the specific activity of LKB1/STRADalpha complexes associated with these MO25alpha mutants was either normal or only moderately reduced (Figure 3C). This suggests the presence of additional interactions between MO25alpha and LKB1 in the presence of STRADalpha.
###end p 41
###begin p 42
###xml 189 193 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Boudeau3">[15]</xref>
###xml 335 343 319 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g002">Figure 2</xref>
###xml 689 698 649 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figure 3D</xref>
###xml 865 874 813 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figure 3D</xref>
###xml 1024 1033 964 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figure 3D</xref>
###xml 1162 1170 1094 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g002">Figure 2</xref>
Earlier studies revealed that mutation of a conserved Arg240 residue located on the concave surface of MO25alpha reduced interaction with LKB1 complexed to STRADalpha lacking the WEF motif [15]. Arg240 might be involved in interaction with LKB1, as this residue is located on the concave surface of MO25alpha, distant from STRADalpha (Figure 2). To further investigate the role of Arg240 in enabling MO25alpha to associate with LKB1/STRADalpha, we mutated Arg240 alone or in combination with residues in either the WEF pocket (Met260) or the alphaB STRADalpha binding sites (Arg227). We found that mutation of Arg240 alone does not prevent MO25alpha from interacting with LKB1/STRADalpha (Figure 3D). However, a double MO25alpha mutant lacking Arg240 and a key concave surface-binding site in the alphaB site (Arg227), markedly impaired binding to LKB1/STRADalpha (Figure 3D). A triple mutant of MO25alpha lacking Arg240, Arg227, and the WEF pocket site failed to associate with LKB1/STRADalpha and stimulate LKB1 activity (Figure 3D). These observations indicate that MO25alpha possesses three sites with which it can interact with the LKB1/STRADalpha complex (Figure 2), namely two STRADalpha binding regions (extensive concave MO25alpha surface and WEF pocket) as well as a putative LKB1 binding site (Arg240).
###end p 42
###begin title 43
The STRADalpha/MO25alpha Interaction Is Similar to the CDK/Cyclin Complex
###end title 43
###begin p 44
###xml 199 215 191 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g004">Figure 4A and 4B</xref>
###xml 217 221 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Jeffrey1">[30]</xref>
###xml 554 558 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Jeffrey1">[30]</xref>
###xml 847 851 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Jeffrey1">[30]</xref>
###xml 907 916 880 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g004">Figure 4B</xref>
###xml 1069 1078 1022 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1E</xref>
###xml 1284 1293 1229 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1B</xref>
Inspection of the STRADalpha/MO25alpha complex reveals an unexpected resemblance to the interaction between activated cyclin-dependent kinase 2 (CDK2) and its activating regulatory subunit cyclin A (Figure 4A and 4B) [30]. Although MO25alpha/beta isoforms are not related to cyclins at the primary sequence level, both proteins consist of multiple alpha-helical repeats. Crystal structures of CDK2/cyclin A complex have revealed cyclin A binds to the so-called "PSTAIRE (alphaC) helix" of CDK2 kinase as well as the loop immediately preceding this helix [30]. Comparisons between free CDK2 and CDK2/cyclin A complex structures have shown that the cyclin molecule orients a conserved glutamate residue (Glu51) from the alphaC-helix of the protein kinase to allow formation of an ion pair with a lysine residue (Lys33) from the conserved VAIK motif [30], which keeps the CDK2 kinase in a closed conformation (Figure 4B). Similarly, the position of MO25alpha in the STRADalpha/MO25alpha complex is centred on helix alphaC and the loop preceding this helix (alphaB region; Figure 1E). The interaction between Glu118 from the alphaC-helix and Arg100 from the VAIK (VTVR in STRADalpha) motif (analogous to the Glu51-Lys33 interaction in CDK2) is maintained, albeit via two water molecules (Figure 1B).
###end p 44
###begin title 45
Structural comparison of the STRADalpha/MO25alpha interaction.
###end title 45
###begin p 46
###xml 566 570 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-SchulzeGahmen1">[56]</xref>
(A-C) Resemblance of (A) STRADalpha/MO25alpha complex with (B) the CDK2/cyclin A complex (PDB ID 1FIN) and (C) the EGFR/EGFR kinase domain dimer (PDB ID 2GS2). The kinases are shown as green ribbons, with the binding partners shown as blue ribbons. The alphaC-helix, where the binding of the "activator" is centred, is labelled. (D and E) Comparison of the STRADalpha structure (green) to the active and inactive structures of CDK2 and EGFR (gray). Residues from the C-lobe of STRADalpha (152-431) were superimposed onto the structures of inactive CDK2 (PDB ID 1HCK [56]) and EGFR kinase (PDB ID 2GS7), and active CDK2 (PDB ID 1JST) and EGFR (PDB ID 2GS2). The activation loop of STRADalpha has been coloured yellow, and the activation loops of CDK2 and EGFR kinase are shown in magenta.
###end p 46
###begin p 47
###xml 183 192 183 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g004">Figure 4C</xref>
###xml 466 475 462 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g004">Figure 4C</xref>
###xml 477 481 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Zhang1">[31]</xref>
###xml 916 932 900 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g004">Figure 4D and 4E</xref>
###xml 1133 1137 1117 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Zhang1">[31]</xref>
###xml 1233 1242 1213 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g001">Figure 1C</xref>
Another example in which this type of interaction is involved in regulating the activity of protein kinases is the ligand-induced dimerisation of the EGFR family of tyrosine kinases (Figure 4C). Although this type of dimer has not been observed in solution, crystal structures and biochemical data demonstrate the importance of dimer formation that involves the intermolecular interaction of the EGFR alphaC-helix on one monomer and the C-lobe on the other monomer (Figure 4C) [31]. A comparison between the structure of active, dimeric EGFR kinase with the monomeric form reveals the role of dimerisation for keeping the EGFR kinase in the closed and active conformation. Similarly, the structure of STRADalpha in complex with MO25alpha resembles the closed conformation of both CDK2 and EGFR kinase, with its activation loop and alphaC-helix positioned in an orientation that is typical of active protein kinases (Figure 4D and 4E). Such regulatory mechanism may also explain why some members of the EGFR family of kinases that lack kinase activity and are classified as pseudokinases (Her3) are still able to exert their function [31], despite their "inactivatory" substitutions, similar to what has been observed for STRADalpha (Figure 1C).
###end p 47
###begin p 48
###xml 515 519 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-White1">[32]</xref>
###xml 548 552 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Kannan1">[33]</xref>
###xml 553 557 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Taylor1">[35]</xref>
###xml 589 593 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Filippakopoulos1">[36]</xref>
The interactions in the EGFR homodimer, the CDK2/cyclin A heterodimer, and the STRADalpha/MO25alpha complex are similar only in general topological terms. However, it appears that the mechanism of protein kinase interaction via helix alphaC with their activity modulators is wider than previously thought, and not exclusive to the CDK family of kinases. Indeed, there are many examples of how protein kinases are stabilised in an active conformation via helix alphaC. These include members of the MAP kinase family [32], the AGC family of kinases ([33]-[35], and several tyrosine kinases ([36]). Although in these examples the alphaC-helix is stabilised by flanking N- or C-terminal sequences/domains present in the same polypeptide chain, the mechanisms of allosteric activation are similar.
###end p 48
###begin title 49
STRADalpha ATP Binding Is Markedly Enhanced by MO25alpha
###end title 49
###begin p 50
###xml 510 514 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Hiratsuka1">[37]</xref>
###xml 621 624 601 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Mukherjee1">[4]</xref>
###xml 651 652 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 652 653 632 633 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 741 762 709 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g005">Figure 5A, 5B, and 5E</xref>
###xml 765 766 733 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 766 767 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 895 916 855 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g005">Figure 5C, 5D, and 5E</xref>
###xml 1044 1065 996 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g005">Figure 5A, 5B, and 5E</xref>
###xml 1120 1141 1072 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g005">Figure 5C, 5D, and 5E</xref>
###xml 1407 1423 1347 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g005">Figure 5A and 5B</xref>
###xml 1442 1444 1382 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1489 1491 1425 1427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1559 1561 1491 1493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1652 1661 1580 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g005">Figures 5</xref>
###xml 1666 1668 1594 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s006">S6</xref>
###xml 1729 1731 1657 1659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1790 1793 1718 1721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Mukherjee1">[4]</xref>
Although MO25alpha appears to induce a STRADalpha active conformation similar to CDK2/cyclin A, the effect of this "active conformation" cannot be measured through ATPase/kinase activity due to STRADalpha being a pseudokinase. Instead, we investigated how affinity of ATP for STRADalpha was modulated by its interaction with MO25alpha. We used the fluorescent ATP analogue 2',3'-O-2,4,6-trinitrophenyl-ATP (TNP-ATP), whose fluorescence emission is enhanced upon its titration with ATP-binding proteins/enzymes [37], a feature that has previously been exploited to measure equilibrium binding constants of kinases for ATP [4]. Using this approach, the Kd of STRADalpha for TNP-ATP in the absence of MO25alpha was determined to be 1.1 microM (Figure 5A, 5B, and 5E). Kd values of STRADalpha for ATP and ADP were also assessed by their ability to displace bound TNP-ATP and found to be 2-3 microM (Figure 5C, 5D, and 5E). Strikingly, addition of an equimolar amount of MO25alpha to STRADalpha enhanced binding of TNP-ATP by an order of magnitude (Figure 5A, 5B, and 5E) and TNP-ATP displacement by two orders of magnitude (Figure 5C, 5D, and 5E), indicating significantly stronger affinity compared to the interaction of ATP as a substrate to active kinases. In contrast, the binding of STRADalpha to TNP-ATP was not enhanced by addition of the MO25alpha(R227A/M260A) mutant that is unable to bind STRADalpha (Figure 5A and 5B). The lack of a Mg2+ binding motif on STRADalpha suggests that Mg2+ should not contribute to the STRADalpha-ATP interaction. Indeed, Mg2+ did not affect binding of STRADalpha to TNP-ATP or displacement of TNP-ATP by ATP or ADP (Figures 5 and S6). This is in contrast with the CASK "pseudokinase," where Mg2+ reportedly inhibits ATP binding and hence kinase activity [4].
###end p 50
###begin title 51
###xml 72 74 64 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
MO25alpha enhances the ability of STRADalpha to bind ATP and APD in a Mg2+-independent manner.
###end title 51
###begin p 52
###xml 408 409 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 409 410 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 411 412 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 412 415 372 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 428 429 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 429 432 389 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 437 438 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 438 439 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 748 769 704 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 932 933 886 887 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1169 1170 1095 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1170 1171 1096 1097 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 1172 1173 1098 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1173 1176 1099 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 1298 1319 1224 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 1493 1494 1417 1418 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1496 1497 1420 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1497 1498 1421 1422 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1538 1559 1462 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
(A) Fluorescence emission spectra (excitation 410 nm) of TNP-ATP (5 microM) bound to the indicated forms of STRADalpha (2 microM) and/or MO25alpha (2 microM). A reference cuvette containing TNP-ATP (5 microM) only was subtracted as background. (B) Saturation binding experiments for STRADalpha, STRADalpha complexed to MO25alpha (WT, wild type), and MO25alpha (R227A/M260A) to TNP-ATP. Bound was defined as (Fx/Fmax) [R], where Fmax and Fx are maximal and fractional fluorescence (recorded at 540 nm), respectively, and [R] equals the binding capacity, defined by the enzyme concentration, fixed at 1.5 microM. Equilibrium binding curves were then fitted to the quadratic equation suitable for tight binding interactions with ligand depletion (see Materials and Methods). Data are shown as an average of three independent experiments+/-SEM. (C and D) Displacement of TNP-ATP by ATP and ADP in the presence and absence of 0.5 mM MgCl2. Concentrations of TNP-ATP (5 microM), STRADalpha (2 microM), and STRADalpha/MO25alpha (2 microM) complex were fixed, and either ATP or ADP was titrated (0.05-500 microM). Emission at 540 nm was recorded, and the fractional occupancy (Fx/Fmax) was plotted as a function of added nucleotide concentration. Dose-response curves were fitted using GraphPad-PRISM (see Materials and Methods). Data are shown as an average of three independent experiments+/-SEM. (E) Equilibrium binding constants for TNP-ATP, ATP, and ADP in the presence and absence of 0.5 mM MgCl2. Kd values were calculated as explained in Materials and Methods.
###end p 52
###begin p 53
###xml 73 75 69 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 130 132 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 172 174 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 245 247 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 462 464 458 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 581 583 569 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 744 746 732 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
It should be noted that although STRADalpha does not appear to require Mg2+ ions to bind ATP, most cellular ATP is complexed to Mg2+ ions. Although there is no space for Mg2+ to bind in the canonical protein kinase mode through the DFG motif, Mg2+ ions could reside in the solvent-exposed region of the phosphate moiety, replacing one of the ordered water molecules. Alternatively, it is possible that conformational changes in the structure could accommodate Mg2+ without affecting the ability of STRADalpha to bind MO25alpha (see below). As mentioned previously, the canonical Mg2+ coordinating residues appear to have been substituted through evolution with positively charged residues (Arg240 and H200), thus making redundant the role of Mg2+ ions.
###end p 53
###begin title 54
ATP Stimulates Binding of STRADalpha to MO25alpha
###end title 54
###begin p 55
###xml 192 201 180 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g006">Figures 6</xref>
###xml 206 208 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s007">S7</xref>
###xml 320 336 300 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g006">Figure 6A and 6E</xref>
###xml 407 416 387 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s007">Figure S7</xref>
###xml 421 429 401 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s008">Table S1</xref>
###xml 458 459 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 459 460 439 440 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 491 507 467 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g006">Figure 6A and 6E</xref>
###xml 618 634 594 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g006">Figure 6A and 6E</xref>
###xml 666 667 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 667 669 643 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d2</sub>
###xml 735 736 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 736 738 712 714 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d1</sub>
###xml 765 781 737 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g006">Figure 6A and 6E</xref>
###xml 863 872 827 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g006">Figure 6A</xref>
###xml 1187 1203 1131 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g006">Figure 6B and 6E</xref>
###xml 1320 1329 1264 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figure 3A</xref>
###xml 1352 1356 1296 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 1894 1910 1798 1814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g006">Figure 6C and 6E</xref>
###xml 2016 2032 1912 1928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g006">Figure 6D and 6E</xref>
###xml 2298 2306 2174 2182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g005">Figure 5</xref>
###xml 2560 2564 2428 2432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Lew1">[38]</xref>
To further investigate the functional consequences of ATP binding to STRADalpha, we employed quantitative SPR measurements to evaluate how ATP influenced affinity of STRADalpha for MO25alpha (Figures 6 and S7). In the absence of ATP, the binding of STRADalpha for MO25alpha was fitted to a single-site binding equation (Figure 6A and 6E). From measuring the rate constants for association and dissociation (Figure S7 and Table S1), the dissociation constant Kd was calculated as 3.8 microM (Figure 6A and 6E). However, in the presence of ATP, binding could be fitted to a two-site binding equation (Hill slope of 0.4, Figure 6A and 6E). The second binding constant (Kd2) was measured as 12 nM, over two orders of magnitude higher than Kd1 calculated as 2.5 microM (Figure 6A and 6E). MgATP enhanced binding of STRADalpha to MO25alpha, to a similar extent as ATP (Figure 6A). These results indicate that binding of ATP to STRADalpha leads to a high-affinity MO25alpha interaction site being exposed. Mutation of Met260 in the WEF binding pocket of MO25alpha did not significantly affect binding of MO25alpha to STRADalpha, nor did it influence the effect of ATP at enhancing interaction (Figure 6B and 6E). It should be noted that this observation contrasts with the data obtained from coexpression studies in 293 cells (Figure 3A) and previous studies [16], in which mutation of Met260 inhibits MO25alpha binding to STRADalpha, suggesting that the WEF pocket is required for cellular complex assembly of MO25alpha and STRADalpha. Mutation of Arg227, in the newly identified concave site of MO25alpha, which interacts with the alphaB site of STRADalpha, virtually abolished binding of STRADalpha observed by SPR in the absence of ATP. In the presence of ATP or MgATP, no two-site binding of MO25alpha(R227A) to STRADalpha was detected, displaying only low micromolar binding with a single site (Figure 6C and 6E). A double MO25alpha(R227A/M260A) mutant failed to interact with STRADalpha even in the presence of ATP (Figure 6D and 6E). These results indicate that the key STRADalpha high-affinity binding site on MO25alpha lies on the concave surface and is only recognized by STRADalpha in the presence of ATP. Together with the finding that MO25alpha also enhances affinity of STRADalpha for ATP (Figure 5), this suggests that the interaction of ATP and MO25alpha to STRADalpha is cooperative. A similar synergistic mechanism is observed for the PKA catalytic subunit where a nucleotide analog was shown to stabilise a complex with the PKI inhibitory peptide [38]. However, in the case of PKA/PKI interaction the gamma-phosphate cannot be transferred because there is no acceptor, whereas in case of STRAD, it cannot be transferred because of the lack of a base catalyst.
###end p 55
###begin title 56
###xml 64 66 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
ATP enhances the ability of STRADalpha to bind MO25alpha in a Mg2+-independent manner.
###end title 56
###begin p 57
###xml 394 395 362 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 693 694 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 694 695 650 651 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 745 746 701 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 746 747 702 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 767 768 723 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 768 769 724 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 778 786 734 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s008">Table S1</xref>
###xml 830 839 786 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s007">Figure S7</xref>
###xml 871 872 827 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 872 873 828 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 914 915 870 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 915 916 871 872 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 919 920 875 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 920 921 876 877 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 922 923 878 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 923 924 879 880 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 930 951 886 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 1146 1155 1102 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s007">Figure S7</xref>
###xml 1160 1181 1116 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
Binding of STRADalpha to MO25alpha was assessed in an SPR BIAcore assay by immobilising (A) MO25alpha (WT, wild type), (B) MO25alpha (M260A), (C) MO25alpha (R227A), and (D) MO25alpha (R227A/M260A) to a CM5 sensor chip, and STRADalpha was allowed to bind over 50 s by injecting different concentrations over a range of 0.4 nM to 5 microM in the presence or absence of 0.1 mM ATP and/or 1 mM MgCl2. Response levels for specific binding of STRADalpha to MO25alpha was plotted against STRADalpha concentration (log scale), using, where appropriate, a variable slope model to determine the Hill slope from the data. Similar results were obtained in at least two separate experiments. (E). Reported Kd values were calculated by measuring association (ka) and dissociation (kd) rates (Table S1) from the BIAcore sensorgram data shown in Figure S7 and using Scrubber-2 software. Kd values reported here were calculated as Kd = kd/ka (see Materials and Methods). Equilibrium binding constants were also calculated from a saturation binding model, and similar values were obtained, as expected for specific binding that follows the law of mass action (see Figure S7 and Materials and Methods). ND = not determined.
###end p 57
###begin title 58
ATP and MO25alpha Are Required for STRADalpha Activation of LKB1
###end title 58
###begin p 59
###xml 355 364 335 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g007">Figure 7A</xref>
###xml 466 475 442 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g007">Figure 7B</xref>
###xml 574 583 550 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g007">Figure 7C</xref>
###xml 828 837 788 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g007">Figure 7D</xref>
###xml 908 917 868 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g007">Figure 7D</xref>
###xml 1404 1413 1340 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g007">Figure 7E</xref>
Having established that ATP increases the affinity of STRADalpha-MO25alpha interaction, we next explored whether ATP binding to STRADalpha also affects assembly and activity of the LKB1 heterotrimeric complex. Using the STRADalpha-ATP structure, a number of STRADalpha mutants were designed to disrupt binding of the adenine or phosphate moieties of ATP (Figure 7A). Four of these were indeed unable to interact with TNP-ATP in the presence or absence of MO25alpha (Figure 7B). Interestingly, these mutants also affected association with LKB1 when coexpressed in 293 cells (Figure 7C), suggesting that binding of ATP to STRADalpha, in the absence of MO25alpha, enhances the ability of STRADalpha to interact with LKB1. However, these mutants were capable of forming complexes with LKB1 when coexpressed with LKB1 and MO25alpha (Figure 7D), that retained catalytic activity as measured by activation of AMPK (Figure 7D). It is possible that binding of MO25alpha to these STRADalpha mutants compensates for their inability to bind ATP, by inducing a closed "active-like" conformation of STRADalpha, capable of binding and activating LKB1. To explore this idea, we generated mutants of STRADalpha incapable of binding to both ATP and MO25alpha. Strikingly, we found that these combined STRADalpha mutants lost their ability to activate LKB1, despite still being capable of forming a heterotrimeric complex (Figure 7E).
###end p 59
###begin title 60
Interaction of ATP and MO25alpha with STRADalpha controls LKB1 activity.
###end title 60
###begin p 61
###xml 1289 1296 1241 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1314 1335 1266 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 1289 1296 <span type="species:ncbi:562">E. coli</span>
(A) The structure of the ATP binding site of STRADalpha in which the key interacting residues are emphasized. (B) Fluorescence emission spectra (excitation 410 nm) of TNP-ATP (5 microM) bound to wild-type and mutant forms of STRADalpha (2 microM) and/or wild-type MO25alpha (2 microM). A reference cuvette containing only TNP-ATP (5 microM) was subtracted as background. A Coomassie Blue-stained SDS-PAGE gel of each form of STRADalpha analysed is shown (GGK = G76D+G78D+K197E, GGR = G76D+G78D+R215E, and GGKR = G76D+G78D+K197E+R215E). (C) Wild-type GST-LKB1 and indicated forms of Flag-STRADalpha were expressed in 293 cells in the absence of MO25alpha. Cells at 36 h posttransfection were lysed and GST-LKB1 affinity purified on glutathione-Sepharose. The purified GST-LKB1 preparation (upper panel), as well as the cell extracts (lower panel), was immunoblotted (IB) with the indicated antibodies. Similar results were obtained in three separate experiments. Dotted line indicates where the gel was cut. (D and E) 293 cells were co-transfected with the indicated constructs of GST-LKB1, Flag-STRADalpha, and Myc-MO25alpha. Cells at 36 h posttransfection were lysed, and GST-LKB1 was affinity purified and assayed for the ability to activate the heterotrimeric AMPK complex expressed in E. coli, as described in Materials and Methods. Kinase activities are representative of three independent assays carried out in triplicate (error bars represent the SD for a single triplicate experiment). Affinity-purified GST-LKB1 preparation (upper panel), as well as cell extracts (lower panel), was immunoblotted with the indicated antibodies.
###end p 61
###begin p 62
###xml 296 305 280 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g003">Figures 3</xref>
###xml 310 311 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g007">7</xref>
###xml 1081 1085 1029 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Jeffrey1">[30]</xref>
Taken together, these observations suggest that the closed "active-like" conformation of STRADalpha is maintained through binding to ATP and/or MO25alpha, and is required for activation of LKB1. Mutations that prevent STRADalpha from binding to ATP or MO25alpha do not affect activation of LKB1 (Figures 3 and 7), suggesting that ATP binding to STRADalpha can compensate for loss of MO25alpha interaction and vice versa. However, loss of both ATP and MO25alpha binding prevents STRADalpha from activating LKB1. Such mutations may leave STRADalpha in the open "inactive-like" conformation incapable of activating LKB1. We have tried unsuccessfully to crystallise STRADalpha in the absence of MO25alpha in order to demonstrate this. Binding of ATP to several kinases, including the EGF receptor tyrosine kinase, promotes the closed, active conformation of these enzymes. Moreover, as discussed above, binding of cyclin to CDK2 is reminiscent of the interaction of STRADalpha with MO25alpha, and interaction of cyclin A is well known to promote the closed active conformation of CDK2 [30].
###end p 62
###begin title 63
PMSE truncation and the stability of STRADalpha.
###end title 63
###begin p 64
###xml 88 96 <span type="species:ncbi:9606">patients</span>
(A) Structure of STRADalpha in which the region beyond Asn252 that is truncated in PMSE patients is coloured in red. (B) A total of 293 cells were cotransfected with the constructs encoding wild-type GST-LKB1 and Myc-MO25alpha together with constructs encoding wild-type or PMSE mutant Flag-STRADalpha. Cells at 36 h posttransfection were lysed, and GST-LKB1 was affinity purified and assayed for ability to phosphorylate the LKBtide peptide. Kinase activities are representative of three independent assays carried out in triplicate (error bars represent the SD for a single experiment carried out in triplicate). Affinity-purified GST-LKB1 preparation (upper panel), as well as cell extracts (lower panel), was immunoblotted (IB) with the indicated antibodies.
###end p 64
###begin title 65
The PMSE Mutation Structurally Impairs STRADalpha
###end title 65
###begin p 66
###xml 126 130 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Puffenberger1">[14]</xref>
###xml 341 350 329 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g008">Figure 8A</xref>
###xml 729 738 701 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g008">Figure 8B</xref>
###xml 858 867 826 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g008">Figure 8B</xref>
###xml 1156 1160 1120 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Puffenberger1">[14]</xref>
###xml 29 35 <span type="species:ncbi:9606">humans</span>
###xml 935 943 <span type="species:ncbi:9606">patients</span>
###xml 1147 1155 <span type="species:ncbi:9606">patients</span>
The PMSE-causing mutation in humans results in a STRADalpha truncation at residue 251, thus removing the last 180 amino acids [14]. Inspection of the STRADalpha structure reveals that this mutation would delete almost half of the C-terminal lobe of the pseudokinase domain, beginning with structurally vital components such as helix alphaF (Figure 8A). This could destabilize the STRADalpha protein, as helix alphaF forms numerous hydrophobic interactions within the C-lobe of the pseudokinase domain, which would become solvent exposed in the PMSE mutant. We attempted to express the PMSE-STRADalpha (residues 1-251) mutant in 293 cells and found that it was expressed at significantly lower levels than full-length STRADalpha (Figure 8B), consistent with this fragment being unstable. Moreover, STRADalpha (1-251) failed to interact with or activate LKB1 (Figure 8B). These results confirm that the STRADalpha mutation found in PMSE patients represents a loss-of-function mutation that would be unable to stimulate the LKB1 pathway. This could account for the elevated mTOR pathway activity that was observed in neuronal cells derived from PMSE patients [14].
###end p 66
###begin title 67
Concluding Remarks
###end title 67
###begin p 68
###xml 376 380 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 465 469 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Wang1">[19]</xref>
###xml 484 488 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Graham1">[17]</xref>
###xml 509 513 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Conti1">[18]</xref>
We have described the first structure of the STRADalpha pseudokinase and its interaction with MO25alpha, a heterodimeric interaction within the heterotrimer LKB1 tumour suppressor complex. A key discovery is the identification of an unexpected extensive interaction between STRADalpha and the concave surface of MO25alpha, previously proposed to harbour a ligand binding site [16]. Armadillo repeat proteins that are structurally related to MO25alpha, such as PUM1 [19], beta-catenin [17], and importin-alpha [18], also bind their macromolecular partners along their concave surface. In general topological terms, the STRADalpha/MO25alpha complex resembles the interaction between CDK2 and cyclin A, and the EGFR/EGFR dimer, and provides another example of protein kinase regulatory mechanism via helix alphaC.
###end p 68
###begin p 69
###xml 1173 1181 1113 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g009">Figure 9</xref>
Our data show that, despite lacking most essential catalytic residues, STRADalpha has maintained its ability to adopt a closed active-like conformation, which binds ATP and possesses an ordered activation loop similar to active protein kinases. This closed conformation is stabilized through binding of ATP and/or MO25alpha. Moreover, binding of MO25alpha to STRADalpha markedly enhances affinity for ATP, and binding of ATP to STRADalpha stimulates interaction with MO25alpha. Our findings support a model in which binding of either MO25alpha or ATP is sufficient to enable STRADalpha to activate LKB1. Consistent with this, mutant forms of STRADalpha that are incapable of binding both ATP and MO25alpha can no longer activate LKB1, whereas mutant forms of STRADalpha that retain the ability to bind either ATP or MO25alpha still activate LKB1. Thus, the closed active-like conformation, rather than catalytic phosphoryl transfer activity, is likely to be the key to the mechanism by which STRADalpha activates the LKB1 tumour suppressor. A model of how STRADalpha/MO25alpha might interact and activate LKB1 based on known mutagenesis and structural data is presented in Figure 9. Future work may establish other examples of pseudokinases that, like STRADalpha, regulate signal transduction networks through their conformational state alone.
###end p 69
###begin title 70
Model of how STRADalpha/MO25alpha might interact and activate LKB1.
###end title 70
###begin p 71
The model is based on known mutagenesis and structural data discussed in this paper. Binding of either ATP and/or MO25alpha to STRADalpha induces STRADalpha to adopt a closed conformation, leading to the assembly of a fully active LKB1 complex.
###end p 71
###begin p 72
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Scheeff1">[39]</xref>
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Labesse1">[40]</xref>
Very recent reports have described the structures of VRK3 [39] and ROP2 [40] pseudokinases, both incapable of binding ATP. Both studies support the notion put forward in this paper that pseudokinases may function by means of conformational state rather than catalytic activity, although in an ATP-independent manner.
###end p 72
###begin title 73
Materials and Methods
###end title 73
###begin title 74
General Methods and Buffers
###end title 74
###begin p 75
###xml 311 318 311 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 311 318 <span type="species:ncbi:562">E. coli</span>
Restriction enzyme digests, DNA ligations, and other recombinant DNA procedures were performed using standard protocols. All mutagenesis were performed using the QuickChange site-directed mutagenesis method (Stratagene) with the KOD polymerase (Novagen). DNA constructs used for transfection were purified from E. coli DH5alpha using Qiagen Plasmid kits according to the manufacturer's protocol. All DNA constructs were verified by DNA sequencing, which was performed by the Sequencing Service, College of Life Sciences, University of Dundee, United Kingdom, using DYEnamic ET terminator chemistry (Amersham Biosciences) on Applied Biosystems automated DNA sequencers. Lysis buffer used for HEK 293 cells was 50 mM Tris-HCl (pH 7.5), 1 mM EGTA, 1 mM EDTA, 1% (w/v) Nonidet P40 (substitute), 1 mM sodium orthovanadate, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 0.27 M sucrose, 0.1% (v/v) 2-mercaptoethanol, 1 mM benzamidine, and 0.1 mM PMSF. Buffer A was 50 mM Tris-HCl (pH 7.5), 0.1 mM EGTA, and 0.1% (v/v) 2-mercaptoethanol. SDS sample buffer contained 50 mM Tris-HCl (pH 6.8), 2% (w/v) SDS, 10% (v/v) glycerol, 0.005% (w/v) bromophenol blue, and 1% (v/v) 2-mercaptoethanol. TBS-T buffer was Tris-HCl (pH 7.5), 0.15 M NaCl, and 0.5% (v/v) Tween. All protein concentrations were determined using the Bradford reagent (Bio-Rad) and by measuring the absorbance at 595 nm, unless indicated otherwise.
###end p 75
###begin title 76
Cloning, Protein Expression, and Purification
###end title 76
###begin p 77
###xml 101 108 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 265 269 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Tan1">[41]</xref>
###xml 815 822 787 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s009">Text S1</xref>
###xml 101 108 <span type="species:ncbi:562">E. coli</span>
###xml 595 602 <span type="species:ncbi:4097">Tobacco</span>
###xml 615 618 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
A bicistronic expression system was used to coexpress and purify the STRADalpha/MO25alpha complex in E. coli. Expression vectors were kindly donated by Dr. Roger Williams (University of Cambridge, United Kingdom). The cloning procedure was followed as described in [41]. Briefly, both STRADalpha and MO25alpha genes were subcloned as separate cassettes from the pOPT single vectors into a pOPCH polycistronic vector. Full-length MO25alpha (residues 1-341) was subcloned from a pOPT (no tag) vector as an NdeI/BamH1 insert. STRADalpha (residues 59-431) with an N-terminal 6-His tag followed by a Tobacco Etch Virus (TEV) protease site (sequence MAHHHHHHMENLYFQG) was subcloned from a POPTH vector as a BspE1/Mlu1 insert. For more information on the expression and purification of STRADalpha for activity assays, see Text S1.
###end p 77
###begin p 78
###xml 92 99 84 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 167 170 159 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 275 276 254 255 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 412 413 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 780 781 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 946 948 912 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1634 1638 1589 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Walter1">[21]</xref>
###xml 92 104 <span type="species:ncbi:511693">E. coli BL21</span>
N-terminally 6-His-tagged STRADalpha was coexpressed with untagged full-length MO25alpha in E. coli BL21(DE3)pLysS cells. Cells were grown in Luria Bertani medium to A600 = 0.7 at 37degreesC, before protein expression was induced by the addition of 250 microM isopropyl-beta-d-thiogalactopyranoside (IPTG) and incubated for a further 16 h at 26degreesC. Cells were harvested by centrifugation for 30 min at 3,500g and resuspended in ice-cold lysis buffer (50 mM Tris-HCl [pH 7.8], 50 mM NaCl, 10% glycerol, 20 mM imidazole, 1 mM benzamidine, 0.2 mM EGTA, 0.2 mM EDTA, 0.1 mM PMSF, 0.075% (v/v) beta-mercaptoethanol, 0.5 mg/ml lysozyme, and 0.3 mg/ml DNAse-I. Cells were lysed using a French Press cell disrupter (18,000 psi), and the lysate was cleared by centrifugation at 26,000g for 30 min. The supernatant was then passed through a 0.22-microm filter before loading onto a 5-ml HiTrap IMAC HP column (GE Healthcare) previously charged with Ni2+. The column was then washed with ten volumes of wash buffer (lysis buffer without lysozyme, DNAse-I, and PMSF), and the STRADalpha/MO25alpha complex was eluted by applying a gradient of 20-300 mM imidazole in wash buffer. The sample was then concentrated to 3 ml and loaded onto a Superdex 75 26/60 gel filtration column, pre-equilibrated in 25 mM Tris (pH 7.8) and 1 mM DTT. For the methylated protein complex, the sample was dialyzed into 25 mM Tris-HCl (pH 7.5), 50 mM NaCl, 10% glycerol, 1 mM benzamidine, and 0.075% (v/v) beta-mercaptoethanol after imidazole elution, and subjected to lysine methylation using formaldehyde and dimethylamine-borane complex, as described elsewhere [21]. The methylated STRADalpha/MO25alpha complex was then passed through a desalting column prior to loading onto a gel filtration column as explained above. The binary complex eluted as a single peak, and its purity was assessed by SDS-PAGE.
###end p 78
###begin title 79
Crystallization, Structure Solution, and Refinement
###end title 79
###begin p 80
###xml 134 135 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 380 381 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 383 384 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
The STRADalpha/MO25alpha complex was concentrated to 7.5 mg/ml, followed by addition of ATP to a final concentration of 10 mM and MgCl2 (final concentration of 1 mM). The sitting drop vapour diffusion method was used to grow crystals by mixing 1 microl of protein solution, 1 microl of mother liquor. For the unmethylated complex, the optimised mother liquor consisted of 20 mM Li2SO4, 50 mM sodium citrate (pH 5.6), 6% (v/v) PEG4000. For the methylated complex, the mother liquor was composed of 0.1 M MES (pH 6.4), 10% (v/v) PEG8000. For both conditions, 0.25 microl of 1 M NDSB-256 was added to the crystallisation drop. Rod-shaped crystals of the unmethylated complex appeared after 3 h and grew to 0.05 mm (maximum dimension) after 24 h. The methylated sample yielded bigger crystals that appeared after 24 h and grew to a maximum length of 0.5 mm after 3 d. Crystals were flash frozen in liquid nitrogen after cryoprotection with mother liquor containing 20% (v/v) glycerol (unmethylated) and 25% (v/v) PEG8000 and 10% (v/v) PEG300 (methylated).
###end p 80
###begin p 81
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Collaborative1">[42]</xref>
###xml 200 207 200 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-1000126-t001">Table 1</xref>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Vagin1">[43]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Cowtan1">[44]</xref>
###xml 521 525 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 660 664 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Cowtan1">[44]</xref>
###xml 713 717 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Zhou1">[23]</xref>
###xml 866 870 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Murshudov1">[45]</xref>
###xml 974 978 966 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Emsley1">[46]</xref>
###xml 1047 1048 1039 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1066 1067 1058 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1067 1071 1059 1063 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">free</sub>
###xml 1115 1119 1107 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Laskowski1">[47]</xref>
###xml 1135 1139 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Lovell1">[48]</xref>
###xml 1141 1148 1133 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-1000126-t001">Table 1</xref>
Data were collected at 100 K on stations ID14-3, ID14-4, and ID23-2 at the European Synchrotron Radiation Facility (ESRF) and processed using the MOSFLM and SCALA programs from the CCP4 package [42] (Table 1). The structures of the unmethylated/methylated complexes were solved by a combination of molecular replacement with MOLREP [43] and real-space searches with FFFEAR [44]. An initial molecular replacement run was carried out with MOLREP using the 1.85 A structure (Protein Data Bank ID [PDB ID] 1UPK) of MO25alpha [16] as a search model. Using the resulting phases, the STRADalpha molecule was then located by performing a real-space search with FFFEAR [44] using the 2.1 A structure (PDB ID 1U5R) of TAO2 [23]. Thus, a solution with one complex in the asymmetric unit was found, and the structure was refined by alternating rounds of refinement with REFMAC5 [45] (including TLS refinement during the last macrocycles) and manual model building with the program COOT [46]. For the methylated complex, this resulted in a final model with an R-factor of 0.206 (Rfree = 0.254) that was validated using PROCHECK [47] and MOLPROBITY [48] (Table 1). STRADalpha residues 292-347, 383-385, and 402-424, and MO25alpha residues 337-341 were not associated with clear electron density and were not included in the model.
###end p 81
###begin p 82
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-DeLano1">[49]</xref>
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Kabsch1">[50]</xref>
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Edgar1">[51]</xref>
Figures were prepared using the PyMOL molecular graphics system available at [49]. Secondary structure was analysed using DSSP [50] and sequence alignments were performed using MUSCLE [51], which were edited and displayed using the program ALINE developed by Charlie Bond and Alexander Schuttelkopf.
###end p 82
###begin title 83
Cell Culture, Transfections, and Lysis
###end title 83
###begin p 84
###xml 140 141 140 141 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 564 565 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 121 127 <span type="species:ncbi:9913">bovine</span>
Two hundred ninety-three cells were cultured on 10-cm diameter dishes in 10 ml of DMEM supplemented with 10% (v/v) fetal bovine serum, 2 mM l-glutamine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. For transfection experiments, 3-9 microg of DNA were mixed with 20 microl of 1 mg/ml polyethylenimine (Polysciences) in 1 ml of plain DMEM for each dish; the mixture was left to stand for 30 min and added onto the cells. Cells were lysed 36 h posttransfection in 1 ml of ice-cold lysis buffer per dish. The cell lysates were clarified by centrifugation at 20,000g for 15 min at 4degreesC, and the supernatants divided into aliquots, frozen in liquid nitrogen, and stored at -20degreesC.
###end p 84
###begin title 85
Expression of Fusion Proteins in HEK293 Cells and Affinity Purification
###end title 85
###begin p 86
10-cm diameter dishes of 293 cells were transiently transfected with 3 microg of the pEBG-2Tconstructs together with 3 microg of the indicated pCMV5 constructs as described above. Cells were harvested and lysed 36-h posttransfection, and the clarified lysates were incubated for 1 h on a rotating platform with glutathione-Sepharose (GE Healthcare; 20 microl/dish of lysate) previously equilibrated in lysis buffer. The beads were washed twice with lysis buffer containing 150 mM NaCl and twice with 50 mM Tris HCl, pH 7.5. For immunoblotting analysis, the beads were resuspended in SDS sample buffer after this step and the samples immunoblotted as described above. For protein kinase assays and gel electrophoresis, the beads were washed twice more with Buffer A, and the proteins were eluted from the resin by incubation with the same buffer containing 270 mM sucrose and 20 mM of reduced glutathione. The beads were then removed by filtration through a 0.44-microm filter, and the eluate was divided into aliquots and stored at -80degreesC.
###end p 86
###begin title 87
Assaying LKB1 by Measuring Phosphorylation of the LKBtide Peptide
###end title 87
###begin p 88
###xml 328 332 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Lizcano1">[52]</xref>
###xml 504 506 484 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 848 852 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Alessi2">[53]</xref>
###xml 944 946 910 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
The activity of recombinant LKB1/STRADalpha/MO25alpha complexes was assayed towards the LKBtide peptide substrate. All assays were performed by using 0.35 microg of recombinant proteins expressed and purified from HEK293 cells as described above. Phosphotransferase activity towards the LKBtide peptide (SNLYHQGKFLQTFCGSPLYRRR) [52] was measured in a total assay volume of 50 microl consisting of 50 mM Tris-HCl (pH 7.5), 0.1 mM EGTA, 0.1% (v/v) 2-mercaptoethanol, 10 mM magnesium acetate, 0.1 mM [gamma-32P]ATP (200 cpm/pmol), and 0.2 mM LKBtide peptide. The assays were carried out at 30degreesC and were terminated after 15 min by applying 40 microl of the reaction mixture onto P81 membranes. These were washed in phosphoric acid, and the incorporated radioactivity was measured by scintillation counting as described previously for MAP kinase [53]. One unit (U) of activity represents the incorporation to the substrate of 1 nmol of gamma-32P per minute.
###end p 88
###begin title 89
Assaying LKB1 by Measuring Activation of the Heterotrimeric AMPK Kinase
###end title 89
###begin p 90
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Lizcano1">[52]</xref>
###xml 202 203 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 207 208 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 213 214 198 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 562 564 521 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 629 633 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Dale1">[54]</xref>
###xml 714 716 663 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 980 982 925 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 50 57 <span type="species:ncbi:562">E. coli</span>
The AMPK heterotrimeric complex was purified from E. coli, and the AMPK activity was measured following its phosphorylation with LKB1 as reported by Lizcano et al. [52]; 10 microg of AMPK complex (alpha1beta2gamma1 subunits) was incubated with or without 0.3 ng of wild-type or mutant LKB1/STRADalpha/MO25alpha complex in Buffer A containing 5 mM magnesium acetate and 0.1 mM cold ATP, in a final volume of 20 microl. After incubation at 30degreesC for 30 min, the AMPK kinase activity was determined by adding 30 microl of 5 mM magnesium acetate, 0.1 mM [gamma-32P]ATP (300 cpm/pmol), and 0.2 mM AMARA peptide (AMARAASAAALARRR) [54] as substrate. After incubation for 20 min at 30degreesC, incorporation of gamma-32P into the peptide substrate was determined by applying the reaction mixture onto P81 phosphocellulose paper and scintillation counting as described in the previous section. One unit (U) of activity represents the incorporation to the substrate of 1 nmol of gamma-32P per minute.
###end p 90
###begin title 91
Immunoblotting
###end title 91
###begin p 92
###xml 506 517 <span type="species:ncbi:3704">horseradish</span>
The indicated amounts of cell lysates or purified proteins were subjected to SDS-PAGE and transferred to nitrocellulose membranes. The membranes were blocked for 1 h in TBS-T buffer containing 5% (w/v) skimmed milk. The anti-GST, anti-Flag, and anti-Myc antibodies (Sigma) were diluted 1,000-fold before the membranes were immunoblotted in the same buffer containing the indicated antibodies, for 16 h at 4degreesC. Membranes were then washed six times with TBS-T buffer and incubated with the appropriate horseradish peroxidase-conjugated secondary antibodies (Pierce) in TBS-T buffer containing 10% (w/v) skimmed milk. After repeating the washing steps, detection was performed using the enhanced chemiluminescence reagent (Amersham Pharmacia Biotech), and the films were developed using a film automatic processor (SRX-101; Konica Minolta Medical).
###end p 92
###begin title 93
Protein Expression for Nucleotide Binding and SPR Measurements
###end title 93
###begin p 94
###xml 180 187 172 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 234 237 226 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 435 436 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 786 787 759 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 180 187 <span type="species:ncbi:562">E. coli</span>
For nucleotide binding experiments, wild-type and mutant forms of STRADalpha (residues 54-431) and MO25alpha (residues 1-341) were expressed individually as GST fusion proteins in E. coli. Cells were grown in Luria Bertani medium to A600 = 0.7 at 37degreesC, and protein expression was induced by the addition of 250 microM IPTG and incubated for a further 16 h at 26degreesC. Cells were harvested by centrifugation for 30 min at 3,500g and resuspended in ice-cold wash buffer (50 mM Tris-HCl (pH 7.8), 150 mM NaCl, 5% (v/v) glycerol, 1 mM benzamidine, 1 mM EGTA, 1 mM EDTA, 0.1 mM PMSF, and 0.01% (v/v) beta-mercaptoethanol, supplemented with 0.5 mg/ml lysozyme and 0.3 mg/ml DNAse-I. Cells were lysed by sonication (10 x 10 s pulses) and clarified lysates (by centrifugation at 26,000g) were incubated for 1 h on a rotating platform with glutathione-Sepharose (GE Healthcare; 0.5 ml/l of culture) pre-equilibrated in wash buffer. The beads were then washed with ten column volumes of wash buffer and a further 50 column volumes of high-salt wash buffer containing 500 mM NaCl. Beads were re-equilibrated in ten column volumes of wash buffer, and the proteins were eluted by incubating with PreScission protease for 16 h. Protein eluates were dialysed for 16 h against 5 l of assay buffer containing 50 mM Tris-HCl (pH 7.8), 50 mM NaCl, 270 mM sucrose, and 1 mM DTT, concentrated to 7 mg/ml, divided into aliquots, and stored at -80degreesC.
###end p 94
###begin p 95
###xml 547 549 524 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1108 1110 1063 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 972 975 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
###xml 1037 1040 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
For SPR measurements, wild-type and mutant forms of MO25alpha were expressed and purified as above. His-STRADalpha (residues 59-431) was isolated in complex with MO25alpha as described for crystallisation. After gel filtration (GF) in GF buffer containing 50 mM Tris-HCl (pH 7.8), 50 mM NaCl, 270 mM sucrose, and 0.075% (v/v) beta-mercaptoethanol, the STRADalpha/MO25alpha complex (20 mg) was resuspended in 20 ml of binding buffer (BB), consisting of GF buffer with increased NaCl concentration (300 mM). This sample was passed through 2 ml of Ni2+-agarose beads (Invitrogen), equilibrated in BB, and the beads were washed with 50 column volumes of BB containing 500 mM NaCl and were re-equilibrated with ten column volumes of BB. His-STRADalpha was eluted in binding buffer supplemented with 150 mM imidazole. The eluted His-STRADalpha sample was equally divided and dialyzed against the assay buffer mentioned above. Untagged STRADalpha was obtained by incubation with TEV protease for 16 h at 4degreesC. Uncleaved STRADalpha and the TEV protease were removed by passing the postcleavage sample through Ni2+-agarose beads. His-STRADalpha and untagged STRADalpha were finally dialyzed into assay buffer, concentrated, and stored as above. Protein concentrations were determined by measuring the absorbance of the purified proteins at 280 nm in assay buffer.
###end p 95
###begin title 96
Nucleotide Binding Assays
###end title 96
###begin p 97
###xml 137 138 131 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Fluorescent measurements of TNP-ATP (Molecular Probes), were obtained at 25degreesC in assay buffer (with the addition of 0.5-1.0 mM MgCl2 where indicated) using 1-cm pathlength cuvettes in a VARIAN Cary Eclipse Fluorescence spectrophotometer (Varian). Fluorescence was recorded using a 410-nm/540-nm excitation/emission wavelengths from 500 to 600 nm. In all cases, signal from the TNP-ATP buffer control was subtracted as background. For all binding studies, STRADalpha and STRADalpha mutants were assayed at 2 microM. In cases where STRADalpha/MO25alpha complexes were assayed, wild-type or mutant MO25alpha (2 microM) were preincubated for at least 2 h at 4degreesC prior to a fluorescence binding experiment. For saturation binding experiments, concentrated stocks of TNP-ATP were added stepwise, covering a range of concentrations from 0.05 to 30 microM. For displacement experiments, the concentration of TNP-ATP was fixed at 5 microM, and ATP or ADP was titrated in, covering a range of concentrations from 0.05 to 500 microM. In all assays, concentrated stocks of nucleotides were added to 1 ml of reaction mixture in steps of 0.5 to 1.0 microl, ensuring that the total added volume did not exceed 1% of the total volume of the reaction.
###end p 97
###begin p 98
###xml 74 75 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Copeland1">[55]</xref>
###xml 357 358 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 358 359 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 360 361 360 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 361 364 361 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 603 605 599 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 654 655 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 655 656 651 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 657 658 653 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 658 661 654 657 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 695 705 691 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">([N]&#8722;logEC</sup>
###xml 705 707 701 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 707 708 703 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</sup>
###xml 771 772 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 772 773 768 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 774 775 770 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 775 778 771 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 869 870 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 870 871 866 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 871 872 867 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sup>
###xml 912 914 908 910 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 926 927 922 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 923 927 919 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">log<italic>K</italic></sup>
###xml 927 928 923 924 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 928 929 924 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sup>
###xml 945 946 941 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 946 947 942 943 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 947 954 943 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNP&#8722;ATP</sup>
All data were analysed using GraphPad-PRISM software (). To calculate the Kd values for TNP-ATP, data from saturation binding experiments were fitted to the following quadratic equation suitable for tight binding interactions with ligand depletion [55]:where [RL] equals the concentration of receptor/ligand complex, calculated as the fractional occupancy (Fx/Fmax) x [R]; [R] equals the total binding capacity, fixed at 1.5 microM; and [L] equals the concentration of added TNP-ATP. In the displacement studies, equilibrium constant values for ATP and ADP were calculated by first determining the logEC50 value, using a standard dose-response equation: Fx/Fmax = minimum+(maximum-minimum)/(1+10([N]-logEC50)), where [N] equals the concentration of added nucleotide, and Fx/Fmax represents the fractional occupancy. Equilibrium constants for the competing ATP and ADP (KdN), were fitted using the equation: logEC50 = log(10logKdN x (1+[TNP-ATP]/KdTNP-ATP)).
###end p 98
###begin title 99
SPR Measurements of STRADalpha Binding to MO25alpha
###end title 99
###begin p 100
SPR measurements were performed using a BIAcore T100 instrument. Wild-type and mutant forms of MO25alpha were immobilized on a CM5 sensor chip using standard amine-coupling chemistry, and 10 mM HBS (pH 7.4) was used as the running buffer. The carboxymethyl dextran surface was activated with a 7-min injection of a 1:1 ratio of 0.4 M 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/0.1 M N-hydroxy succinimide (NHS). MO25alpha (5-7 microM) was coupled to the surface with a 1-min injection of protein diluted in 10 mM sodium acetate (pH 5.5). Remaining activated groups were blocked with a 7-min injection of 1 M ethanolamine (pH 8.5). MO25alpha was immobilised on three flow cells of a CM5 chip at densities 1,700-2,500 RU performed at 25degreesC, leaving one flow cell as a reference to subtract any possible nonspecific binding.
###end p 100
###begin p 101
###xml 197 198 189 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
STRADalpha was prepared in running buffer containing 50 mM Tris (pH 7.8), 50 mM NaCl, 270 mM sucrose, 1 mM DTT, 0.005% P20, and 0.1 mg/ml BSA in the presence/absence of 100 microM ATP and 1 mM MgCl2, and injected over all four surfaces at nine concentrations of a 3-fold concentration series (5 microM to 0.3 nM). Each concentration was injected in duplicate over all surfaces. Association was measured for 60 s at a flow rate of 50 microl/min, and dissociation was measured for 3 min. STRADalpha dissociated completely from the MO25alpha surfaces, thus eliminating the need for a regeneration step.
###end p 101
###begin p 102
###xml 347 348 347 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 348 349 348 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 374 375 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 375 376 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 485 486 485 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 486 487 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 509 510 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 510 512 510 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d1</sub>
###xml 515 516 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 516 518 516 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d1</sub>
###xml 519 520 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 520 522 520 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a1</sub>
###xml 527 528 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 528 530 528 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d2</sub>
###xml 533 534 533 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 534 536 534 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d2</sub>
###xml 537 538 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 538 540 538 540 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a2</sub>
###xml 666 667 666 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 718 719 718 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 723 724 723 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 724 728 724 728 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max1</sub>
###xml 745 746 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 746 748 746 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d1</sub>
###xml 752 753 752 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 753 757 753 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max2</sub>
###xml 774 775 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 775 777 775 777 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d2</sub>
###xml 787 788 787 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 788 792 788 792 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max1</sub>
###xml 797 798 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 798 802 798 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max2</sub>
###xml 885 886 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 886 888 886 888 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d1</sub>
###xml 893 894 893 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 894 896 894 896 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d2</sub>
###xml 1082 1083 1082 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1117 1138 1117 1138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">((logEC50&#8722;[STRAD])&#215;H)</sup>
Data were analysed using Scrubber 2 (BioLogic Software) and CLAMP software. Data were double referenced to the reference surface to subtract any possible nonspecific binding and to the blank buffer injections to subtract drift of the target from surface. Data were fitted to a 1:1 or 2:1 binding site model where appropriate. Kinetic association (ka) and dissociation rate (kd) constants were separately determined from the BIAcore sensorgrams, and equilibrium dissociation constants (Kd) were calculated as: Kd1 = kd1/ka1 and Kd2 = kd2/ka2. Equilibrium constants were also independently calculated from a saturation binding curve, by fitting the measured response (R) from specific binding to the following equation: R = (Rmax1[STRAD]/([STRAD]+Kd1))+(Rmax2[STRAD]/([STRAD]+Kd2)), where Rmax1 and Rmax2 are the relative maximal changes in response for sites 1 and 2, respectively, and Kd1 and Kd2 are the equilibrium dissociation constants for sites 1 and 2, respectively. Dose-response curves for calculating the Hill slope (H) of the data were fitted with the following equation: R = minimum+(maximum-minimum)/(1+10((logEC50-[STRAD])xH)) using GraphPad-PRISM software.
###end p 102
###begin title 103
Accession Numbers
###end title 103
###begin p 104
Coordinates and observed structure factor amplitudes have been deposited at the Worldwide Protein Data Bank (wwPDB, ), with accession code 3GNI.
###end p 104
###begin title 105
Supporting Information
###end title 105
###begin p 106
###xml 0 60 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Isolation of the heterodimeric STRAD&#945;/MO25&#945; complex.</bold>
###xml 132 139 116 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 132 139 <span type="species:ncbi:562">E. coli</span>
Isolation of the heterodimeric STRADalpha/MO25alpha complex. (A) Gel filtration profiles of His-STRADalpha/MO25alpha coexpressed in E. coli and crystallised in this study. The elution profile of separately expressed MO25alpha monomer as well as the molecular mass standards aldolase (158 kDa), conalbumin (75 kDa), ovalbumin (43 kDa), carbonic anhydrase (29 kDa), and ribonuclease A (13.7 kDa) are also shown. (B) We analysed, by SDS-PAGE, the fractions in which STRADalpha/MO25alpha dimer and MO25alpha monomer were eluted and stained with Coomassie Blue. There is no evidence for large molecular weight aggregates of His-STRADalpha/MO25alpha. In the His-STRADalpha/MO25alpha purification, a minor low molecular weight eluting shoulder to the main peak was found to consist of mainly uncomplexed His-STRADalpha. Because His-STRADalpha was the subunit used for nickel affinity purification of the complex, it will be expected to be present in excess.
###end p 106
###begin p 107
(1.99 MB TIF)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
###xml 0 53 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Attempts at reactivating the STRAD&#945; pseudokinase.</bold>
###xml 135 142 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 206 208 194 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 604 606 584 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 655 657 635 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 135 142 <span type="species:ncbi:562">E. coli</span>
Attempts at reactivating the STRADalpha pseudokinase. The indicated STRADalpha (residues 59-431) active site mutants were expressed in E. coli and tested for kinase activity in the presence of 0.2 mM gamma-32P-ATP and 10 mM magnesium acetate, (A) alone or (B) in the presence of MO25alpha. Similarly, in (C) and (D), the same mutations were tested in the absence of magnesium acetate. (E-H) STRADalpha active site mutants were combined with mutations/deletions from the P+1 site of the kinase. (E and F) were tested in the presence of magnesium acetate, whereas (G and H) were tested in the absence of Mg2+. In all cases, PKA assayed in the presence of Mg2+ was included as a positive control. (5X = T98A+R100K+G213D+L214F+R215G)
###end p 109
###begin p 110
(3.73 MB TIF)
###end p 110
###begin p 111
Click here for additional data file.
###end p 111
###begin p 112
###xml 0 100 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Characterisation of the MO25&#945; PFPF motif, the STRAD&#945; WEF motif, and effects on LKB1 binding.</bold>
###xml 307 311 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000126-Milburn1">[16]</xref>
###xml 458 459 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 459 460 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 461 462 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 462 463 434 435 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
Characterisation of the MO25alpha PFPF motif, the STRADalpha WEF motif, and effects on LKB1 binding. (A) Comparison of STRADalpha WEF motif, binding to the MO25alpha WEF pocket. WEF motifs from the STRADalpha/MO25alpha complex structure and MO25alpha/peptide complex determined previously by Milburn et al. [16], are superimposed (RMSD = 0.3 A over 35 atoms) and shown as stick models with green and yellow carbon atoms, respectively. Electron density maps (Fo-Fc are shown for the WEF motif determined in this study and contoured at 2.5sigma). (B) The PFPF motif of MO25alpha binds to a STRADalpha hydrophobic pocket, near the ATP binding site. Electron density maps are displayed as described above. (C) The indicated constructs of GST-STRADalpha and untagged MO25alpha were expressed in 293 cells. Cells were lysed 36 h posttransfection and GST-STRADalpha was affinity purified on glutathione-Sepharose. The purified GST-STRADalpha preparation (upper panels), as well as the cell extracts (lower panel), was immunoblotted with the indicated antibodies. STRADalpha R227A mutant, unable to bind MO25alpha, was used as a control. (D) Wild-type GST-LKB1 and indicated forms of Flag-STRADalpha and untagged MO25alpha were cotransfected in 293 cells. Cells 36 h posttransfection were lysed, and GST-LKB1 was affinity purified on glutathione-Sepharose. The purified GST-LKB1 preparations (upper panels), as well as the cell extracts (lower panel), were immunoblotted with the indicated antibodies. (E) Either 0.5 or 1.0 mg of the indicated cell lysates were incubated with 5 microg of the indicated biotinylated peptides conjugated to Streptavidin-Sepharose. Following isolation and washing of the beads, the samples were subjected to SDS-polyacrylamide gel electrophoresis and immunoblotted with the indicated antibodies. (F) Activation of the bacterially expressed AMPK complex using wild-type or mutant LKB1/STRADalpha/MO25alpha complex. The purity of LKB1 complexes was analyzed by SDS-PAGE and colloidal blue staining.
###end p 112
###begin p 113
(3.82 MB TIF)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin p 115
###xml 0 83 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">His-tagged STRAD&#945; and untagged STRAD&#945; bind MO25&#945; with similar affinity.</bold>
###xml 292 313 272 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 720 721 672 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 950 951 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 951 952 891 892 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1002 1003 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 1003 1004 943 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 1024 1025 964 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 1025 1026 965 966 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1076 1085 1016 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s007">Figure S7</xref>
###xml 1090 1098 1030 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s008">Table S1</xref>
###xml 1127 1128 1067 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1128 1129 1068 1069 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1170 1171 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1171 1172 1111 1112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1175 1176 1115 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 1176 1177 1116 1117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1178 1179 1118 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 1179 1180 1119 1120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 1186 1207 1126 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 1333 1342 1273 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s007">Figure S7</xref>
###xml 1347 1368 1287 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 145 148 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
###xml 250 253 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
His-tagged STRADalpha and untagged STRADalpha bind MO25alpha with similar affinity. His-STRADalpha was treated in the presence or absence of His-TEV protease to remove the 6-His purification tag and then repurified using nickel agarose to remove His-TEV and any uncleaved His-STRADalpha (see Materials and Methods). Binding was assessed by SPR analyses where (A) MO25alpha(WT) (wild type), (B) MO25alpha(M260A), (C) MO25alpha(R227A), and (D) MO25alpha(R227A/M260A) were immobilised to a CM5 sensor chip. Equivalent concentrations of His-STRADalpha or untagged STRADalpha, were allowed to bind over 50 s by injecting different concentrations over a range of 0.4 nM to 5 microM, in the presence of 0.1 mM ATP and 1 mM MgCl2. Response level for specific binding of STRADalpha to MO25alpha was plotted against STRADalpha concentration (log scale), using a variable slope model (where appropriate) to determine the Hill slope from the data. (E). Reported Kd values were calculated by measuring association (ka) and dissociation (kd) rates from the BIAcore sensorgram data shown in Figure S7 and Table S1, using Scrubber-2 software. Kd values reported here were calculated as Kd = kd/ka (see Materials and Methods). Equilibrium binding constants were also calculated from a saturation binding model, and similar values were obtained. (see Figure S7 and Materials and Methods).
###end p 115
###begin p 116
(0.66 MB TIF)
###end p 116
###begin p 117
Click here for additional data file.
###end p 117
###begin p 118
###xml 0 50 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sequence conservation of STRAD&#945; and MO25&#945;.</bold>
Sequence conservation of STRADalpha and MO25alpha. Sequence alignment (dark blue = conserved, white = not conserved) of STRADalpha (A) and MO25alpha (B) of the indicated species. Alignments were performed with MUSCLE and edited and displayed using ALINE (Charlie Bond and Alex Schuttelkopf). A graph of residues involved in STRADalpha/MO25alpha interaction against their contact area (green bars), is displayed. Height of the bar represents the contact area (atom pairs closer than 3.9 A, analysed by CONTACT from the CCP4 package), divided by the molecular weight of the participating amino acid. Key STRADalpha catalytic motifs and the WEF motif are boxed. The secondary structure (analysed by DSSP) is shown in red. Dotted lines represent residues missing in our structural model.
###end p 118
###begin p 119
(1.93 MB TIF)
###end p 119
###begin p 120
Click here for additional data file.
###end p 120
###begin p 121
###xml 84 85 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 86 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Binding of STRAD&#945;/MO25&#945; complex to the ATP fluorescent analog TNP-ATP&#177;MgCl<sub>2</sub>.</bold>
###xml 209 210 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 234 235 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 235 236 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 237 238 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 238 241 220 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 253 254 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 254 257 236 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 262 263 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 263 264 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 573 594 551 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 597 598 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 598 599 576 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 722 723 682 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 748 749 708 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Binding of STRADalpha/MO25alpha complex to the ATP fluorescent analog TNP-ATP+/-MgCl2. Saturation binding experiments for STRADalpha/MO25alpha complex to TNP-ATP in the presence/absence of 0.5 mM and 1 mM MgCl2. Bound was defined as (Fx/Fmax)[R], where Fmax and Fx are maximal and fractional fluorescence (recorded at 540 nm), respectively, and [R] equals the binding capacity, defined by the enzyme concentration, fixed at 1.5 microM. Equilibrium binding curves were then fitted to the quadratic equation suitable for tight binding interactions with ligand depletion (see Materials and Methods). Kd values were calculated as: 0.09+/-0.03 microM, 0.23+/-0.06 microM, and 0.09+/-0.04 microM for TNP-ATP, TNP-ATP+0.5 mM MgCl2, and TNP-ATP+1.0 mM MgCl2, respectively. Data shown are the average of two independent experiments.
###end p 121
###begin p 122
(0.30 MB TIF)
###end p 122
###begin p 123
Click here for additional data file.
###end p 123
###begin p 124
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Primary BIAcore sensorgrams used to calculate equilibrium rate constants in </bold>
###xml 76 85 76 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S3</bold>
###xml 76 85 76 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s003"><bold>Figure S3</bold></xref>
###xml 85 89 85 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and</bold>
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 89 90 89 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>K</italic></bold>
###xml 90 91 90 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 90 102 90 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>d</sub> values in </bold>
###xml 102 110 102 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 102 110 102 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000126-g006"><bold>Figure 6</bold></xref>
###xml 110 111 110 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 158 179 158 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
Primary BIAcore sensorgrams used to calculate equilibrium rate constants in Figure S3 andKd values in Figure 6. Data analyses were undertaken as described in Materials and Methods. Similar results were obtained in two separate experiments carried out in duplicate. Kinetic fits in (A, C, and E) correlate well with equilibrium fits in (B, D, and F), respectively, as is expected for specific binding that follows the law of mass action.
###end p 124
###begin p 125
(1.08 MB TIF)
###end p 125
###begin p 126
Click here for additional data file.
###end p 126
###begin p 127
###xml 0 79 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STRAD&#945; interaction rate constants for MO25&#945; (WT) and MO25&#945; mutants.</bold>
###xml 79 80 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 80 81 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 86 87 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 87 88 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 140 149 128 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000126.s007">Figure S7</xref>
STRADalpha interaction rate constants for MO25alpha (WT) and MO25alpha mutants.ka and kd values were calculated from BIAcore sensorgrams in Figure S7. Error values are given in parentheses.
###end p 127
###begin p 128
(0.05 MB PDF)
###end p 128
###begin p 129
Click here for additional data file.
###end p 129
###begin p 130
###xml 0 54 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Purification and kinase activity assays of STRAD&#945;.</bold>
Purification and kinase activity assays of STRADalpha.
###end p 130
###begin p 131
(0.03 MB DOC)
###end p 131
###begin p 132
Click here for additional data file.
###end p 132
###begin title 133
References
###end title 133
###begin article-title 134
###xml 37 42 <span type="species:ncbi:9606">human</span>
The protein kinase complement of the human genome.
###end article-title 134
###begin article-title 135
Emerging roles of pseudokinases.
###end article-title 135
###begin article-title 136
Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension.
###end article-title 136
###begin article-title 137
CASK functions as a Mg2+-independent neurexin kinase.
###end article-title 137
###begin article-title 138
Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum.
###end article-title 138
###begin article-title 139
Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.
###end article-title 139
###begin article-title 140
Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase.
###end article-title 140
###begin article-title 141
MO25 isoforms interact with STRADalpha/beta enhancing their ability to bind, activate and localise LKB1.
###end article-title 141
###begin article-title 142
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.
###end article-title 142
###begin article-title 143
###xml 24 29 <span type="species:ncbi:9606">human</span>
A role for LKB1 gene in human cancer beyond the peutz-jeghers syndrome.
###end article-title 143
###begin article-title 144
Lkb1-dependent signaling pathways.
###end article-title 144
###begin article-title 145
TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.
###end article-title 145
###begin article-title 146
AMPK phosphorylation of raptor mediates a metabolic checkpoint.
###end article-title 146
###begin article-title 147
Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a homozygous 7-kilobase deletion in LYK5.
###end article-title 147
###begin article-title 148
Analysis of the LKB1-STRAD-MO25 complex.
###end article-title 148
###begin article-title 149
Crystal structure of MO25 alpha in complex with the c terminus of the pseudo kinase STE20-related adaptor.
###end article-title 149
###begin article-title 150
Crystal structure of a beta-catenin/tcf complex.
###end article-title 150
###begin article-title 151
Crystallographic analysis of the specific yet versatile recognition of distinct nuclear localization signals by karyopherin alpha.
###end article-title 151
###begin article-title 152
Crystal structure of a pumilio homology domain.
###end article-title 152
###begin article-title 153
STRADalpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7.
###end article-title 153
###begin article-title 154
Lysine methylation as a routine rescue strategy for protein crystallization.
###end article-title 154
###begin article-title 155
Crystal-structure of the catalytic subunit of cyclic adenosinemonophosphate dependent protein-kinase.
###end article-title 155
###begin article-title 156
Crystal structure of the TAO2 kinase domain: activation and specificity of a ste20p MAP3K.
###end article-title 156
###begin article-title 157
Regulation of protein kinases; controlling activity through activation segment conformation.
###end article-title 157
###begin article-title 158
Active and inactive protein kinases: Structural basis for regulation.
###end article-title 158
###begin article-title 159
The conformational plasticity of protein kinases.
###end article-title 159
###begin article-title 160
Structural characterisation and functional significance of transient protein-protein interactions.
###end article-title 160
###begin article-title 161
Inference of macromolecular assemblies from crystalline state.
###end article-title 161
###begin article-title 162
Structural basis for AMP binding to mammalian AMP-activated protein kinase.
###end article-title 162
###begin article-title 163
Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.
###end article-title 163
###begin article-title 164
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
###end article-title 164
###begin article-title 165
Molecular basis of MAPK-activated protein kinase 2:p38 assembly.
###end article-title 165
###begin article-title 166
Structural and functional diversity of the microbial kinome.
###end article-title 166
###begin article-title 167
Lining the pockets of kinases and phosphatases.
###end article-title 167
###begin article-title 168
PKA: a portrait of protein kinase dynamics.
###end article-title 168
###begin article-title 169
Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation.
###end article-title 169
###begin article-title 170
Biological activities and spectroscopic properties of chromophoric and fluorescent analogs of adenine nucleoside and nucleotides, 2',3'-O-(2,4,6-trinitrocyclohexadienylidene) adenosine derivatives.
###end article-title 170
###begin article-title 171
Synergistic binding of nucleotides and inhibitors to cAMP-dependent protein kinase examined by acrylodan fluorescence spectroscopy.
###end article-title 171
###begin article-title 172
Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site.
###end article-title 172
###begin article-title 173
###xml 10 27 <span type="species:ncbi:5811">Toxoplasma gondii</span>
ROP2 from Toxoplasma gondii: a virulence factor with a protein-kinase fold and no enzymatic activity.
###end article-title 173
###begin article-title 174
###xml 82 98 <span type="species:ncbi:562">escherichia coli</span>
A modular polycistronic expression system for overexpressing protein complexes in escherichia coli.
###end article-title 174
###begin article-title 175
The CCP4 suite: programs for protein crystallography.
###end article-title 175
###begin article-title 176
Molrep: an automated program for molecular replacement.
###end article-title 176
###begin article-title 177
Modified phased translation functions and their application to molecular fragment location.
###end article-title 177
###begin article-title 178
Refinement of macromolecular structures by the maximum-likelihood method.
###end article-title 178
###begin article-title 179
Coot: model-building tools for molecular graphics.
###end article-title 179
###begin article-title 180
PROCHECK: a program to check the stereochemical quality of protein structures.
###end article-title 180
###begin article-title 181
Structure validation by Calpha geometry: phi,psi and Cbeta deviation.
###end article-title 181
###begin article-title 182
Use of PyMOL as a communications tool for molecular science.
###end article-title 182
###begin article-title 183
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.
###end article-title 183
###begin article-title 184
MUSCLE: multiple sequence alignment with high accuracy and high throughput.
###end article-title 184
###begin article-title 185
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.
###end article-title 185
###begin article-title 186
Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf.
###end article-title 186
###begin article-title 187
###xml 122 127 <span type="species:ncbi:4932">yeast</span>
Similar substrate recognition motifs for mammalian AMP-activated protein kinase, higher plant HMG-CoA reductase kinase-A, yeast SNF1, and mammalian calmodulin-dependent protein kinase I.
###end article-title 187
###begin article-title 188
###xml 38 43 <span type="species:ncbi:9606">human</span>
High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design.
###end article-title 188
###begin title 189
Abbreviations
###end title 189
###begin p 190
polyhydramnios, megalencephaly, symptomatic epilepsy
###end p 190
###begin p 191
root mean square deviation
###end p 191
###begin p 192
surface plasmon resonance
###end p 192
###begin p 193
The authors have declared that no competing interests exist.
###end p 193
###begin p 194
This work was supported by a TENOVUS Scotland studentship (EZ), a Wellcome Trust Senior Research Fellowship (DMFvA), the Medical Research Council (DRA), and the pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck & Co., Merck KgaA, and Pfizer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 194

